Additional Information
Book Details
Abstract
No dental office should be without this quick-reference drug guide! Mosby's Dental Drug Reference, 12th Edition profiles the most commonly used drugs in dentistry, with emphasis on dental-specific considerations. More than 800 drug monographs make it easy to find information such as dosages, indications, contraindications, interactions, precautions, side effects, and serious reactions. Online resources include over 100 additional drug monographs, photos of common oral complications, patient education guides, and more. From lead editor Arthur Jeske, a well-known researcher and author in dental pharmacology, this pocket-sized reference provides the current, concise drug information you need at the point of care.
- More than 800 drug monographs include each drug’s generic name, pronunciation, brand names, drug class, controlled substances schedule, mechanism of action, uses or indications, doses and routes of administration, side effects/adverse reactions, contraindications, precautions, pharmacokinetics, drug interactions of concern to dentistry, and more.
- Detailed dental considerations at the end of each monograph include an easy-to-use, bulleted list of specific dental-related information as well as general drug information.
- Durable, pocket-sized format provides essential drug information at a glance, and makes this guide ideal for chairside use.
- Emphasis on oral health, prevention, and treatment from the dental hygienist’s perspective makes it easier to use drug information for patient and family education.
- Coverage of oral contraceptives provides dental information on these commonly used drugs, often known only by their brand names.
- Primers in the front of the guide include information on biologic agents, medication-related osteonecrosis of the jaw, and a list of online resources for the management of medically compromised patients along with management of common oral lesions.
- Evolve companion website includes more than 100 additional monographs, photos of common oral complications, patient education guides, information on herbs and alternative medicine, and more.
- NEW! More than 50 new monographs include newly released, FDA-approved drugs and up-to-date content on the latest drug therapies.
Table of Contents
| Section Title | Page | Action | Price |
|---|---|---|---|
| Front Cover | cover | ||
| IFC_Evolve page | IFC1 | ||
| Additional Monographs on Evolve | IFC2 | ||
| Mosby's Dental Drug Reference | i | ||
| Copyright Page | iv | ||
| Drug Monograph Content Contributors and Reviewers | v | ||
| Preface | vii | ||
| A Detailed Guide to Mosby’s Dental Drug Reference, Twelfth Edition | vii | ||
| Table Of Contents | ix | ||
| Internet References for Additional Drug Information and Professional Guidelines | xi | ||
| Medication-Related Osteonecrosis of the Jaw | xiii | ||
| Monoclonal Antibodies and Other Biologic Drugs | xv | ||
| Summary: | xv | ||
| Classification: | xv | ||
| Dental Considerations for Monoclonal Antibodies/Biologically Targeted Agents | xv | ||
| General: | xv | ||
| Consultations: | xvi | ||
| Teach Patient/Family to: | xvi | ||
| Reference: | xvi | ||
| abacavir | 1 | ||
| Category and Schedule | 1 | ||
| Drug Class: | 1 | ||
| Mechanism of Action | 1 | ||
| Uses | 1 | ||
| Pharmacokinetics | 1 | ||
| Indications and Dosages | 1 | ||
| ► HIV Infection (in combination with other antiretrovirals) | 1 | ||
| PO | 1 | ||
| Adults. | 1 | ||
| Children (3 mo–16 yr). | 1 | ||
| ► Dosage in Hepatic Impairment | 1 | ||
| Mild Impairment. | 1 | ||
| Moderate to Severe Impairment. | 1 | ||
| Side Effects/Adverse Reactions | 1 | ||
| Adults | 1 | ||
| abarelix | 2 | ||
| Category and Schedule | 2 | ||
| Drug Class: | 2 | ||
| Mechanism of Action | 2 | ||
| Uses | 2 | ||
| Pharmacokinetics | 2 | ||
| Indications and Dosages | 2 | ||
| ► Prostate Cancer | 2 | ||
| IM | 2 | ||
| Adults, Elderly. | 2 | ||
| Side Effects/Adverse Reactions | 2 | ||
| Frequent | 2 | ||
| Occasional | 2 | ||
| Rare | 2 | ||
| Precautions and Contraindications | 3 | ||
| Drug Interactions of Concern to Dentistry | 3 | ||
| Serious Reactions | 3 | ||
| Dental Considerations | 3 | ||
| General: | 3 | ||
| Consultations: | 3 | ||
| Teach Patient/Family to: | 3 | ||
| abatacept | 3 | ||
| Category and Schedule | 3 | ||
| Drug Class: | 3 | ||
| Mechanism of Action | 3 | ||
| Uses | 3 | ||
| Pharmacokinetics | 3 | ||
| Indications and Dosages | 3 | ||
| ► Rheumatoid Arthritis (moderate to severe) in patients who have had an inadequate response to one or more disease-modifying antirheumatic drugs | 3 | ||
| IV | 4 | ||
| Adults. | 4 | ||
| Children. | 4 | ||
| abciximab | 5 | ||
| Category and Schedule | 5 | ||
| Drug Class: | 5 | ||
| Mechanism of Action | 5 | ||
| Uses | 5 | ||
| Pharmacokinetics | 5 | ||
| Indications and Dosages | 5 | ||
| ► Percutaneous Coronary Intervention (PCI) | 5 | ||
| absorbable gelatin sponge | 6 | ||
| Category and Schedule | 6 | ||
| Drug Class: | 6 | ||
| Mechanism of Action | 6 | ||
| Uses | 6 | ||
| Pharmacokinetics | 6 | ||
| Indications and Dosages | 6 | ||
| ► Dental Use | 6 | ||
| Adult. | 6 | ||
| Side Effects/Adverse Reactions | 6 | ||
| acamprosate calcium | 7 | ||
| Category and Schedule | 7 | ||
| Drug Class: | 7 | ||
| Mechanism of Actions | 7 | ||
| Uses | 7 | ||
| Pharmacokinetics | 7 | ||
| Indications and Dosages | 7 | ||
| ► Maintenance of Alcohol Abstinence | 7 | ||
| PO | 7 | ||
| Adult. | 7 | ||
| Side Effects/Adverse Reactions | 7 | ||
| Precautions and Contraindications | 7 | ||
| Caution: | 7 | ||
| Drug Interactions of Concern to Dentistry | 7 | ||
| Dental Considerations | 7 | ||
| Teach Patient/Family to: | 7 | ||
| General: | 7 | ||
| Consultations: | 8 | ||
| Teach Patient/Family to: | 8 | ||
| acarbose | 8 | ||
| Category and Schedule | 8 | ||
| Drug Class: | 8 | ||
| Mechanism of Action | 8 | ||
| Uses | 8 | ||
| Pharmacokinetics | 8 | ||
| acebutolol | 9 | ||
| Category and Schedule | 9 | ||
| Drug Class: | 9 | ||
| Mechanism of Action | 9 | ||
| Uses | 9 | ||
| Pharmacokinetics | 9 | ||
| Indications and Dosages | 10 | ||
| ► Mild-to-Moderate Hypertension | 10 | ||
| acetaminophen | 11 | ||
| Category and Schedule | 11 | ||
| Drug Class: | 11 | ||
| Mechanism of Action | 11 | ||
| Uses | 11 | ||
| Pharmacokinetics | 11 | ||
| Indications and Dosages | 12 | ||
| ► Analgesia and Antipyresis | 12 | ||
| PO | 12 | ||
| Adults, Elderly. | 12 | ||
| acetazolamide | 13 | ||
| Category and Schedule | 13 | ||
| Drug Class: | 13 | ||
| Mechanism of Action | 13 | ||
| Uses | 13 | ||
| Pharmacokinetics | 13 | ||
| Indications and Dosages | 14 | ||
| ► Glaucoma | 14 | ||
| acetohexamide | 15 | ||
| Category and Schedule | 15 | ||
| Drug Class: | 15 | ||
| Mechanism of Action | 15 | ||
| Uses | 15 | ||
| Pharmacokinetics | 15 | ||
| Indications and Dosages | 15 | ||
| ► Diabetes Mellitus | 15 | ||
| PO | 15 | ||
| Adults, Elderly. | 15 | ||
| Side Effects/Adverse Reactions | 16 | ||
| Frequent | 16 | ||
| Occasional | 16 | ||
| Precautions and Contraindications | 16 | ||
| Caution: | 16 | ||
| Drug Interactions of Concern to Dentistry | 16 | ||
| Serious Reactions | 16 | ||
| Dental Considerations | 16 | ||
| General: | 16 | ||
| Consultations: | 16 | ||
| Teach Patient/Family to: | 16 | ||
| acetylcholine chloride | 17 | ||
| Category and Schedule | 17 | ||
| Drug Class: | 17 | ||
| Mechanism of Action | 17 | ||
| Uses | 17 | ||
| Pharmacokinetics | 17 | ||
| Indications and Dosages | 17 | ||
| ► Production of Miosis | 17 | ||
| Intraocular | 17 | ||
| Adults, Elderly. | 17 | ||
| Side Effects/Adverse Reactions | 17 | ||
| Rare | 17 | ||
| Precautions and Contraindications | 17 | ||
| Drug Interactions of Concern to Dentistry | 17 | ||
| Serious Reactions | 17 | ||
| Dental Considerations | 17 | ||
| General: | 17 | ||
| Uses | 18 | ||
| Pharmacokinetics | 18 | ||
| Indications and Dosages | 18 | ||
| ► Adjunctive Treatment of Viscid Mucus Secretions from Chronic Bronchopulmonary Disease and for Pulmonary Complications of Cystic Fibrosis | 18 | ||
| Nebulization | 18 | ||
| acetylcysteine | 17 | ||
| acitretin | 19 | ||
| Category and Schedule | 19 | ||
| Drug Class: | 19 | ||
| Mechanism of Action | 19 | ||
| Uses | 19 | ||
| Pharmacokinetics | 19 | ||
| Indications and Dosages | 19 | ||
| ► Psoriasis | 19 | ||
| PO | 19 | ||
| Adults, Elderly. | 19 | ||
| Side Effects/Adverse Reactions | 20 | ||
| Frequent | 20 | ||
| Occasional | 20 | ||
| Precautions and Contraindications | 20 | ||
| Caution: | 20 | ||
| Drug Interactions of Concern to Dentistry | 20 | ||
| Serious Reactions | 20 | ||
| Dental Considerations | 20 | ||
| General: | 20 | ||
| Consultations: | 20 | ||
| Teach Patient/Family to: | 20 | ||
| acyclovir | 21 | ||
| Category and Schedule | 21 | ||
| Drug Class: | 21 | ||
| Mechanism of Action | 21 | ||
| Uses | 21 | ||
| Pharmacokinetics | 21 | ||
| Indications and Dosages | 21 | ||
| ► Genital Herpes (initial episode) | 21 | ||
| adalimumab | 23 | ||
| Category and Schedule | 23 | ||
| Drug Class: | 23 | ||
| Mechanism of Action | 23 | ||
| Uses | 23 | ||
| Pharmacokinetics | 23 | ||
| Indications and Dosages | 23 | ||
| ► Rheumatoid Arthritis | 23 | ||
| Subcutaneous | 23 | ||
| Adults, Elderly. | 23 | ||
| Side Effects/Adverse Reactions | 23 | ||
| Frequent | 23 | ||
| Occasional | 23 | ||
| Rare | 23 | ||
| Precautions and Contraindications | 23 | ||
| Caution: | 23 | ||
| Drug Interactions of Concern to Dentistry | 23 | ||
| Serious Reactions | 23 | ||
| Dental Considerations | 23 | ||
| General: | 23 | ||
| Consultations: | 24 | ||
| Teach Patient/Family to: | 24 | ||
| adapalene | 24 | ||
| Category and Schedule | 24 | ||
| Drug Class: | 24 | ||
| Mechanism of Action | 24 | ||
| Uses | 24 | ||
| Pharmacokinetics | 24 | ||
| Indications and Dosages | 24 | ||
| ► Acne Vulgaris | 24 | ||
| Topical | 24 | ||
| Adults, Elderly, Children older than 12 yr. | 24 | ||
| Side Effects/Adverse Reactions | 24 | ||
| Frequent | 24 | ||
| Occasional | 24 | ||
| Precautions and Contraindications | 24 | ||
| Drug Interactions of Concern to Dentistry | 24 | ||
| Serious Reactions | 24 | ||
| Dental Considerations | 24 | ||
| General: | 24 | ||
| Teach Patient/Family to: | 25 | ||
| adefovir | 25 | ||
| Category and Schedule | 25 | ||
| Drug Class: | 25 | ||
| Mechanism of Action | 25 | ||
| Uses | 25 | ||
| Pharmacokinetics | 25 | ||
| Indications and Dosages | 25 | ||
| ► Chronic Hepatitis B in Patients with Normal Renal Function | 25 | ||
| aflibercept | 26 | ||
| Category and Schedule | 26 | ||
| Drug Class: | 26 | ||
| Mechanism of Action | 26 | ||
| Uses | 26 | ||
| Pharmacokinetics | 26 | ||
| Indications and Dosages | 26 | ||
| ► Age-Related Macular Degeneration (AMD) | 26 | ||
| albendazole | 27 | ||
| Category and Schedule | 27 | ||
| Drug Class: | 27 | ||
| Mechanism of Action | 27 | ||
| Uses | 27 | ||
| Pharmacokinetics | 27 | ||
| Indications and Dosages | 27 | ||
| ► Neurocysticercosis | 27 | ||
| PO | 27 | ||
| Adults, Elderly weighing more than 60 kg. | 27 | ||
| Adults, Elderly weighing less than 60 kg. | 27 | ||
| ► Cystic Hydatid | 28 | ||
| PO | 28 | ||
| Adults, Elderly weighing more than 60 kg. | 28 | ||
| Side Effects/Adverse Reactions | 28 | ||
| Frequent | 28 | ||
| Occasional | 28 | ||
| Precautions and Contraindications | 28 | ||
| Drug Interactions of Concern to Dentistry | 28 | ||
| Serious Reactions | 28 | ||
| Dental Considerations | 28 | ||
| General: | 28 | ||
| Consultations: | 28 | ||
| albiglutide | 28 | ||
| Category and Schedule | 28 | ||
| Drug Class: | 28 | ||
| Mechanism of Action | 28 | ||
| Uses | 28 | ||
| Pharmacokinetics | 28 | ||
| Indications and Dosages | 29 | ||
| ► Type 2 Diabetes Mellitus | 29 | ||
| Adults. | 29 | ||
| Side Effects/Adverse Reactions | 29 | ||
| Frequent | 29 | ||
| Occasional | 29 | ||
| Precautions and Contraindications | 29 | ||
| Drug Interactions of Concern to Dentistry | 29 | ||
| Serious Reactions | 29 | ||
| Dental Considerations | 29 | ||
| General: | 29 | ||
| Consultations: | 29 | ||
| Teach Patient/Family to: | 30 | ||
| albuterol | 30 | ||
| Category and Schedule | 30 | ||
| Drug Class: | 30 | ||
| Mechanism of Action | 30 | ||
| Uses | 30 | ||
| Pharmacokinetics | 30 | ||
| Indications and Dosages | 30 | ||
| ► Bronchospasm | 30 | ||
| PO | 30 | ||
| alclometasone | 31 | ||
| Category and Schedule | 31 | ||
| Drug Class: | 31 | ||
| Mechanism of Action | 32 | ||
| Uses | 32 | ||
| Pharmacokinetics | 32 | ||
| Indications and Dosages | 32 | ||
| ► Atopic Dermatitis, Contact Dermatitis, Dermatitis, Discoid Lupus Erythematosus, Eczema, Exfoliative Dermatitis, Granuloma Annulare, Lichen Planus, Lichen Simplex, Polymorphous Light Eruption, Pruritus, Psoriasis, Rhus Dermatitis, Seborrheic Dermatitis, Xerosis | 32 | ||
| Topical | 32 | ||
| Adults, Adolescents, Children 1 yr and older. | 32 | ||
| Side Effects/Adverse Reactions | 32 | ||
| Frequent | 32 | ||
| Occasional | 32 | ||
| Rare | 32 | ||
| Precautions and Contraindications | 32 | ||
| Drug Interactions of Concern to Dentistry | 32 | ||
| Serious Reactions | 32 | ||
| Dental Considerations | 32 | ||
| General: | 32 | ||
| Teach Patient/Family to: | 32 | ||
| interleukin-2 (aldesleukin) | 32 | ||
| Category and Schedule | 32 | ||
| Drug Class: | 32 | ||
| Mechanism of Action | 33 | ||
| Uses | 33 | ||
| Pharmacokinetics | 33 | ||
| Indications and Dosages | 33 | ||
| ► Metastatic Melanoma, Metastatic Renal Cell Carcinoma | 33 | ||
| IV | 33 | ||
| Adults 18 yr and older. | 33 | ||
| Side Effects/Adverse Reactions | 33 | ||
| Frequent | 33 | ||
| Occasional | 33 | ||
| Rare | 33 | ||
| Precautions and Contraindications | 33 | ||
| Drug Interactions of Concern to Dentistry | 33 | ||
| Serious Reactions | 33 | ||
| Dental Considerations | 34 | ||
| General: | 34 | ||
| Consultations: | 34 | ||
| Teach Patient/Family to: | 34 | ||
| alefacept | 34 | ||
| Category and Schedule | 34 | ||
| Drug Class: | 34 | ||
| alemtuzumab | 35 | ||
| Category and Schedule | 35 | ||
| Drug Class: | 35 | ||
| Mechanism of Action | 35 | ||
| Uses | 35 | ||
| Pharmacokinetics | 35 | ||
| Indications and Dosages | 35 | ||
| ► Plaque Psoriasis | 35 | ||
| IV | 35 | ||
| Uses | 36 | ||
| Pharmacokinetics | 36 | ||
| Indications and Dosages | 36 | ||
| ► Chronic Lymphocytic Leukemia | 36 | ||
| IV | 36 | ||
| Adults, Elderly. | 36 | ||
| Side Effects/Adverse Reactions | 36 | ||
| Frequent | 36 | ||
| Occasional | 36 | ||
| Precautions and Contraindications | 36 | ||
| Drug Interactions of Concern to Dentistry | 36 | ||
| Serious Reactions | 36 | ||
| Dental Considerations | 36 | ||
| General: | 36 | ||
| Consultations: | 37 | ||
| Teach Patient/Family to: | 37 | ||
| alendronate sodium | 37 | ||
| Category and Schedule | 37 | ||
| Drug Class: | 37 | ||
| Mechanism of Action | 37 | ||
| Uses | 37 | ||
| Pharmacokinetics | 37 | ||
| Indications and Dosages | 37 | ||
| ► Osteoporosis (in Men) | 37 | ||
| PO | 37 | ||
| Adults, Elderly. | 37 | ||
| ► Glucocorticoid-Induced Osteoporosis | 38 | ||
| alfuzosin | 39 | ||
| Category and Schedule | 39 | ||
| Drug Class: | 39 | ||
| Mechanism of Action | 39 | ||
| Uses | 39 | ||
| Pharmacokinetics | 39 | ||
| Indications and Dosages | 39 | ||
| ► Bph | 39 | ||
| PO | 39 | ||
| Adults. | 39 | ||
| Side Effects/Adverse Reactions | 39 | ||
| Frequent | 39 | ||
| Occasional | 39 | ||
| Rare | 39 | ||
| Precautions and Contraindications | 39 | ||
| Caution: | 39 | ||
| Drug Interactions of Concern to Dentistry | 39 | ||
| Serious Reactions | 40 | ||
| Dental Considerations | 40 | ||
| General: | 40 | ||
| Consultations: | 40 | ||
| Teach Patient/Family to: | 40 | ||
| alglucosidase alfa | 40 | ||
| Category and Schedule | 40 | ||
| Drug Class: | 40 | ||
| Mechanism of Action | 40 | ||
| Uses | 40 | ||
| Pharmacokinetics | 40 | ||
| Indications and Dosages | 40 | ||
| ► Replacement Therapy for Pompe Disease | 40 | ||
| IV Infusion | 40 | ||
| Adults. | 40 | ||
| Children (1 mo–3.5 yr. at first infusion). | 40 | ||
| Side Effects/Adverse Reactions | 40 | ||
| Frequent | 40 | ||
| Precautions and Contraindications | 41 | ||
| Caution: | 41 | ||
| Drug Interactions of Concern to Dentistry | 41 | ||
| Serious Reactions | 41 | ||
| Dental Considerations | 41 | ||
| General: | 41 | ||
| Teach Patient/Family to: | 41 | ||
| aliskiren | 41 | ||
| Category and Schedule | 41 | ||
| Drug Class: | 41 | ||
| Mechanism of Action | 41 | ||
| Uses | 41 | ||
| Pharmacokinetics | 41 | ||
| Indications and Dosages | 42 | ||
| ► Hypertension (Monotherapy) | 42 | ||
| Adults. | 42 | ||
| Side Effects/Adverse Reactions | 42 | ||
| Frequent | 42 | ||
| Occasional | 42 | ||
| Rare | 42 | ||
| Precautions and Contraindications | 42 | ||
| Drug Interactions of Concern to Dentistry | 42 | ||
| Serious Reactions | 42 | ||
| Dental Considerations | 42 | ||
| General: | 42 | ||
| Consultations: | 42 | ||
| Teach patient/family to: | 42 | ||
| alitretinoin | 42 | ||
| Category and Schedule | 42 | ||
| Drug Class: | 42 | ||
| Mechanism of Action | 42 | ||
| allopurinol | 43 | ||
| Category and Schedule | 43 | ||
| Drug Class: | 43 | ||
| Mechanism of Action | 43 | ||
| Uses | 43 | ||
| Pharmacokinetics | 43 | ||
| Indications and Dosages | 43 | ||
| ► KS Skin Lesions | 43 | ||
| Topical | 43 | ||
| Adults. | 43 | ||
| Side Effects/Adverse Reactions | 43 | ||
| Frequent | 43 | ||
| Precautions and Contraindications | 43 | ||
| Caution: | 43 | ||
| Drug Interactions of Concern to Dentistry | 43 | ||
| Serious Reactions | 43 | ||
| Dental Considerations | 43 | ||
| General: | 43 | ||
| Pharmacokinetics | 44 | ||
| Indications and Dosages | 44 | ||
| ► Chronic Gouty Arthritis | 44 | ||
| almotriptan malate | 45 | ||
| Category and Schedule | 45 | ||
| Drug Class: | 45 | ||
| Mechanism of Action | 45 | ||
| Uses | 45 | ||
| Pharmacokinetics | 45 | ||
| Indications and Dosages | 45 | ||
| ► Migraine Headache | 45 | ||
| PO | 45 | ||
| Adults, Elderly. | 45 | ||
| ► Dosage in Renal Impairment | 45 | ||
| Side Effects/Adverse Reactions | 45 | ||
| Frequent | 45 | ||
| Occasional | 45 | ||
| Precautions and Contraindications | 45 | ||
| Caution: | 45 | ||
| Drug Interactions of Concern to Dentistry | 46 | ||
| Serious Reactions | 46 | ||
| Dental Considerations | 46 | ||
| General: | 46 | ||
| Consultations: | 46 | ||
| Teach Patient/Family to: | 46 | ||
| alogliptin | 46 | ||
| Category and Schedule | 46 | ||
| Drug Class: | 46 | ||
| Mechanism of Action | 46 | ||
| Uses | 46 | ||
| Pharmacokinetics | 46 | ||
| Indications and Dosages | 46 | ||
| ► Type 2 Diabetes Mellitus | 46 | ||
| PO | 46 | ||
| Adults. | 46 | ||
| Side Effects/Adverse Reactions | 47 | ||
| Frequent | 47 | ||
| Occasional | 47 | ||
| Precautions and Contraindications | 47 | ||
| Drug Interactions of Concern to Dentistry | 47 | ||
| Serious Reactions | 47 | ||
| Dental Considerations | 47 | ||
| General: | 47 | ||
| Consultations: | 47 | ||
| Teach Patient/Family to: | 48 | ||
| alprazolam | 48 | ||
| Category and Schedule | 48 | ||
| Drug Class: | 48 | ||
| Mechanism of Action | 48 | ||
| Uses | 48 | ||
| Pharmacokinetics | 48 | ||
| Indications and Dosages | 48 | ||
| ► Anxiety Disorders | 48 | ||
| alprostadil (prostaglandin e1, pge1) | 50 | ||
| Category and Schedule | 50 | ||
| Mechanism of Action | 50 | ||
| Uses | 50 | ||
| Pharmacokinetics | 50 | ||
| Indications and Dosages | 50 | ||
| ► Maintain Patency of Ductus Arteriosus | 50 | ||
| IV Infusion | 50 | ||
| Neonates. | 50 | ||
| ► Impotence | 50 | ||
| Pellet, Intracavernosal | 50 | ||
| Adults. | 50 | ||
| Side Effects/Adverse Reactions | 50 | ||
| Frequent | 50 | ||
| Occasional | 50 | ||
| Precautions and Contraindications | 50 | ||
| Caution: | 50 | ||
| Drug Interactions of Concern to Dentistry | 50 | ||
| alvimopan | 51 | ||
| Category and Schedule | 51 | ||
| Drug Class: | 51 | ||
| Mechanism of Action | 51 | ||
| Uses | 51 | ||
| Pharmacokinetics | 51 | ||
| Indications and Dosages | 51 | ||
| ► Postoperative Control of Ileus | 51 | ||
| Adult. | 51 | ||
| Side Effects/Adverse Reactions | 51 | ||
| Frequent | 51 | ||
| Occasional | 51 | ||
| Precautions and Contraindications | 51 | ||
| Drug Interactions of Concern to Dentistry | 51 | ||
| Serious Reactions | 51 | ||
| Dental Considerations | 51 | ||
| General: | 51 | ||
| Consultations: | 51 | ||
| Teach patient/family to: | 51 | ||
| amantadine hydrochloride | 52 | ||
| Category and Schedule | 52 | ||
| Drug Class: | 52 | ||
| Mechanism of Action | 52 | ||
| Uses | 52 | ||
| Pharmacokinetics | 52 | ||
| Indications and Dosages | 52 | ||
| ► Prevention and Symptomatic Treatment of Respiratory Illness Caused by Influenza A Virus | 52 | ||
| ambenonium | 53 | ||
| Category and Schedule | 53 | ||
| Drug Class: | 53 | ||
| Mechanism of Action | 53 | ||
| Uses | 53 | ||
| Pharmacokinetics | 53 | ||
| Indications and Dosages | 53 | ||
| ► Myasthenia Gravis | 53 | ||
| PO | 53 | ||
| Adults. | 53 | ||
| Side Effects/Adverse Reactions | 53 | ||
| Frequent | 53 | ||
| Occasional | 53 | ||
| Rare | 54 | ||
| Precautions and Contraindications | 54 | ||
| Caution: | 54 | ||
| Drug Interactions of Concern to Dentistry | 54 | ||
| Serious Reactions | 54 | ||
| Dental Considerations | 54 | ||
| General: | 54 | ||
| Consultations: | 54 | ||
| Teach Patient/Family to: | 54 | ||
| ambrisentan | 54 | ||
| Category and Schedule | 54 | ||
| Drug Class: | 54 | ||
| amcinonide | 55 | ||
| Category and Schedule | 55 | ||
| Drug Class: | 55 | ||
| Mechanism of Action | 55 | ||
| Uses | 55 | ||
| Pharmacokinetics | 55 | ||
| Indications and Dosages | 55 | ||
| ► Pulmonary Arterial Hypertension | 55 | ||
| Adult. | 55 | ||
| Side Effects/Adverse Reactions | 55 | ||
| Frequent | 55 | ||
| Occasional | 55 | ||
| Precautions and Contraindications | 55 | ||
| Drug Interactions of Concern to Dentistry | 55 | ||
| Serious Reactions | 55 | ||
| Dental Considerations | 55 | ||
| General: | 55 | ||
| Consultations: | 55 | ||
| Teach patient/family to: | 55 | ||
| Uses | 56 | ||
| Pharmacokinetics | 56 | ||
| Indications and Dosages | 56 | ||
| ► Dermatoses | 56 | ||
| Topical | 56 | ||
| Adults, Elderly. | 56 | ||
| Side Effects/Adverse Reactions | 56 | ||
| Frequent | 56 | ||
| Occasional | 56 | ||
| Rare | 56 | ||
| Precautions and Contraindications | 56 | ||
| Drug Interactions of Concern to Dentistry | 56 | ||
| Serious Reactions | 56 | ||
| Dental Considerations | 56 | ||
| General: | 56 | ||
| Teach Patient/Family to: | 56 | ||
| amifostine | 56 | ||
| Category and Schedule | 56 | ||
| Drug Class: | 56 | ||
| Mechanism of Action | 56 | ||
| Uses | 57 | ||
| Pharmacokinetics | 57 | ||
| Indications and Dosages | 57 | ||
| ► To Reduce Cumulative Renal Toxicity from Repeated Administration of Cisplatin in Patients with Advanced Ovarian Cancer | 57 | ||
| amiloride hydrochloride | 58 | ||
| Category and Schedule | 58 | ||
| Drug Class: | 58 | ||
| Mechanism of Action | 58 | ||
| Uses | 59 | ||
| Pharmacokinetics | 59 | ||
| Indications and Dosages | 59 | ||
| ► To Counteract Potassium Loss Induced by Other Diuretics | 59 | ||
| PO | 59 | ||
| Adults, Children weighing more than 20 kg. | 59 | ||
| Elderly. | 59 | ||
| Children weighing 6–20 kg. | 59 | ||
| ► Dosage in Renal Impairment | 59 | ||
| Side Effects/Adverse Reactions | 59 | ||
| Frequent | 59 | ||
| Occasional | 59 | ||
| Rare | 59 | ||
| Precautions and Contraindications | 59 | ||
| Caution: | 59 | ||
| Drug Interactions of Concern to Dentistry | 59 | ||
| Serious Reactions | 59 | ||
| Dental Considerations | 59 | ||
| General: | 59 | ||
| Consultations: | 60 | ||
| Teach Patient/Family to: | 60 | ||
| aminoglutethimide | 60 | ||
| Category and Schedule | 60 | ||
| Drug Class: | 60 | ||
| Mechanism of Action | 60 | ||
| Uses | 60 | ||
| Pharmacokinetics | 60 | ||
| Indications and Dosages | 60 | ||
| ► Cushing’s Syndrome | 60 | ||
| PO | 60 | ||
| Adults. | 60 | ||
| Side Effects/Adverse Reactions | 60 | ||
| Frequent | 60 | ||
| Occasional | 60 | ||
| Rare | 60 | ||
| Precautions and Contraindications | 60 | ||
| Drug Interactions of Concern to Dentistry | 60 | ||
| Serious Reactions | 60 | ||
| Dental Considerations | 61 | ||
| General: | 61 | ||
| Consultations: | 61 | ||
| Teach Patient/Family to: | 61 | ||
| aminophylline/theophylline | 61 | ||
| Category and Schedule | 61 | ||
| Drug Class: | 61 | ||
| Mechanism of Action | 62 | ||
| Uses | 62 | ||
| Pharmacokinetics | 62 | ||
| Indications and Dosages | 62 | ||
| ► Chronic Bronchospasm | 62 | ||
| aminosalicylic acid | 63 | ||
| Category and Schedule | 63 | ||
| Drug Class: | 63 | ||
| Mechanism of Action | 63 | ||
| Uses | 63 | ||
| Pharmacokinetics | 63 | ||
| Indications and Dosages | 64 | ||
| ► Tuberculosis | 64 | ||
| PO | 64 | ||
| Adults, Elderly. | 64 | ||
| Children. | 64 | ||
| Side Effects/Adverse Reactions | 64 | ||
| Occasional | 64 | ||
| Rare | 64 | ||
| Precautions and Contraindications | 64 | ||
| Caution: | 64 | ||
| Drug Interactions of Concern to Dentistry | 64 | ||
| Serious Reactions | 64 | ||
| Dental Considerations | 64 | ||
| General: | 64 | ||
| Consultations: | 64 | ||
| Teach Patient/Family to: | 64 | ||
| amiodarone hydrochloride | 65 | ||
| Category and Schedule | 65 | ||
| Drug Class: | 65 | ||
| Mechanism of Action | 65 | ||
| Uses | 65 | ||
| Pharmacokinetics | 65 | ||
| Indications and Dosages | 65 | ||
| ► Life-Threatening Recurrent Ventricular Fibrillation or Hemodynamically Unstable Ventricular Tachycardia | 65 | ||
| PO | 65 | ||
| Adults, Elderly. | 65 | ||
| Children. | 65 | ||
| IV Infusion | 65 | ||
| Adults. | 65 | ||
| Side Effects/Adverse Reactions | 65 | ||
| Expected | 65 | ||
| Frequent | 65 | ||
| Occasional | 65 | ||
| Rare | 66 | ||
| Precautions and Contraindications | 66 | ||
| Caution: | 66 | ||
| Drug Interactions of Concern to Dentistry | 66 | ||
| Serious Reactions | 66 | ||
| Dental Considerations | 66 | ||
| General: | 66 | ||
| Consultations: | 66 | ||
| Teach Patient/Family to: | 66 | ||
| amitriptyline hydrochloride | 67 | ||
| Category and Schedule | 67 | ||
| Drug Class: | 67 | ||
| Mechanism of Action | 67 | ||
| Uses | 67 | ||
| Pharmacokinetics | 67 | ||
| Indications and Dosages | 67 | ||
| ► Depression | 67 | ||
| amlexanox | 69 | ||
| Category and Schedule | 69 | ||
| Drug Class: | 69 | ||
| Mechanism of Action | 69 | ||
| Uses | 69 | ||
| Pharmacokinetics | 69 | ||
| Indications and Dosages | 69 | ||
| ► Aphthous Ulcers | 69 | ||
| Topical | 69 | ||
| Adults, Elderly. | 69 | ||
| Side Effects/Adverse Reactions | 69 | ||
| Rare | 69 | ||
| Precautions and Contraindications | 69 | ||
| Caution: | 69 | ||
| Drug Interactions of Concern to Dentistry | 69 | ||
| Serious Reactions | 69 | ||
| Dental Considerations | 69 | ||
| General: | 69 | ||
| Teach Patient/Family to: | 69 | ||
| Uses | 70 | ||
| Pharmacokinetics | 70 | ||
| Indications and Dosages | 70 | ||
| ► Essential Hypertension, Stable Angina and Vasospastic Angina | 70 | ||
| Adult. | 70 | ||
| Child (6–17 yr). | 70 | ||
| Side effects/adverse reactions | 70 | ||
| Frequent | 70 | ||
| Occasional | 70 | ||
| Rare | 70 | ||
| Precautions and Contraindications | 70 | ||
| Drug Interactions of Concern to Dentistry | 70 | ||
| Serious Reactions | 70 | ||
| Dental Considerations | 70 | ||
| General: | 70 | ||
| Consultations: | 71 | ||
| Teach Patient/Family to: | 71 | ||
| amlodipine | 69 | ||
| amoxapine | 71 | ||
| Category and Schedule | 71 | ||
| Drug Class: | 71 | ||
| Mechanism of Action | 71 | ||
| Uses | 71 | ||
| Pharmacokinetics | 71 | ||
| Indications and Dosages | 71 | ||
| ► Depression | 71 | ||
| PO | 71 | ||
| Adults. | 71 | ||
| Adolescents. | 71 | ||
| Elderly. | 71 | ||
| Side Effects/Adverse Reactions | 71 | ||
| Frequent | 71 | ||
| Occasional | 71 | ||
| Rare | 71 | ||
| Precautions and Contraindications | 72 | ||
| Caution: | 72 | ||
| Drug Interactions of Concern to Dentistry | 72 | ||
| Serious Reactions | 72 | ||
| Dental Considerations | 72 | ||
| General: | 72 | ||
| Consultations: | 72 | ||
| Teach Patient/Family to: | 72 | ||
| amoxicillin | 73 | ||
| Category and Schedule | 73 | ||
| Drug Class: | 73 | ||
| Mechanism of Action | 73 | ||
| Uses | 73 | ||
| Pharmacokinetics | 73 | ||
| Indications and Dosages | 73 | ||
| ► Ear, Nose, and Throat Infections | 73 | ||
| amoxicillin/clavulanate potassium | 74 | ||
| Category and Schedule | 74 | ||
| Drug Class: | 74 | ||
| Mechanism of Action | 75 | ||
| Uses | 75 | ||
| Pharmacokinetics | 75 | ||
| Indications and Dosages | 75 | ||
| ► Mild-to-Moderate Infections | 75 | ||
| amphetamine | 76 | ||
| Category and Schedule | 76 | ||
| Drug Class: | 76 | ||
| Mechanism of Action | 76 | ||
| Uses | 76 | ||
| Pharmacokinetics | 76 | ||
| Indications and Dosages | 76 | ||
| ► Adhd | 76 | ||
| PO | 76 | ||
| Adults. | 76 | ||
| Adults, Children older than 12 yr. | 76 | ||
| Children 6–12 yr. | 76 | ||
| Children 3–6 yr. | 77 | ||
| ► Narcolepsy | 77 | ||
| PO | 77 | ||
| Adults. | 77 | ||
| Adults, Children older than 12 yr. | 77 | ||
| Children 6–12 yr. | 77 | ||
| Side Effects/Adverse Reactions | 77 | ||
| Frequent | 77 | ||
| Occasional | 77 | ||
| Precautions and Contraindications | 77 | ||
| Caution: | 77 | ||
| Drug Interactions of Concern to Dentistry | 77 | ||
| Serious Reactions | 77 | ||
| Dental Considerations | 77 | ||
| General: | 77 | ||
| Consultations: | 77 | ||
| Teach Patient/Family to: | 77 | ||
| amphotericin b | 78 | ||
| Category and Schedule | 78 | ||
| Drug Class: | 78 | ||
| Mechanism of Action | 78 | ||
| Uses | 78 | ||
| Pharmacokinetics | 78 | ||
| Indications and Dosages | 78 | ||
| ► Cryptococcosis; Blastomycosis; Systemic Candidiasis; Disseminated Forms of Moniliasis, Coccidioidomycosis, and Histoplasmosis; Zygomycosis; Sporotrichosis; Aspergillosis | 78 | ||
| IV Infusion (Fungizone) | 78 | ||
| Adults, Elderly. | 78 | ||
| Children. | 78 | ||
| ► Invasive Fungal Infections Unresponsive to or Intolerant of Fungizone | 78 | ||
| IV Infusion (Abelcet) | 78 | ||
| Adults, Children. | 78 | ||
| ► Empiric Treatment of Fungal Infections in Patients with Febrile Neutropenia; Aspergillosis, Candidiasis, or Cryptococcosis in Patients with Renal Impairment and Those Who Have Experienced Toxicity or Treatment Failure with Fungizone | 78 | ||
| IV Infusion (Ambisome) | 78 | ||
| amphotericin b, lipid-based | 79 | ||
| Category and Schedule | 79 | ||
| Drug Class: | 79 | ||
| Mechanism of Action | 80 | ||
| Uses | 80 | ||
| Pharmacokinetics | 80 | ||
| Indications and Dosages | 80 | ||
| ► Invasive Fungal Infections Unresponsive to, or Intolerant of, Fungizone. | 80 | ||
| IV Infusion | 80 | ||
| Adults, Children. | 80 | ||
| Side Effects/Adverse Reactions | 80 | ||
| Frequent | 80 | ||
| Occasional | 80 | ||
| Precautions and Contraindications | 80 | ||
| Drug Interactions of Concern to Dentistry | 80 | ||
| Serious Reactions | 80 | ||
| Dental Considerations | 80 | ||
| General: | 80 | ||
| Consultations: | 80 | ||
| Teach Patient/Family to: | 81 | ||
| ampicillin | 81 | ||
| Category and Schedule | 81 | ||
| Drug Class: | 81 | ||
| Mechanism of Action | 81 | ||
| Uses | 81 | ||
| Pharmacokinetics | 81 | ||
| Indications and Dosages | 81 | ||
| ► Respiratory Tract, Skin/Skin-Structure Infections | 81 | ||
| ampicillin sodium | 82 | ||
| Category and Schedule | 82 | ||
| Drug Class: | 82 | ||
| Mechanism of Action | 83 | ||
| Uses | 83 | ||
| Pharmacokinetics | 83 | ||
| Indications and Dosages | 83 | ||
| ► Respiratory Tract, Skin and Skin-Structure Infections | 83 | ||
| ampicillin/sulbactam sodium | 84 | ||
| Category and Schedule | 84 | ||
| Drug Class: | 84 | ||
| Mechanism of Action | 84 | ||
| Uses | 84 | ||
| Pharmacokinetics | 84 | ||
| Indications and Dosages | 84 | ||
| ► Skin and Skin-Structure, Intraabdominal, and Gynecologic Infections | 84 | ||
| IV, IM | 84 | ||
| Adults, Elderly. | 84 | ||
| ► Dosage in Renal Impairment | 84 | ||
| Side Effects/Adverse Reactions | 84 | ||
| Frequent | 84 | ||
| Occasional | 85 | ||
| Precautions and Contraindications | 85 | ||
| Drug Interactions of Concern to Dentistry | 85 | ||
| Serious Reactions | 85 | ||
| Dental Considerations | 85 | ||
| General: | 85 | ||
| Consultations: | 85 | ||
| Teach Patient/Family to: | 85 | ||
| amprenavir | 85 | ||
| Category and Schedule | 85 | ||
| Drug Class: | 85 | ||
| Mechanism of Action | 85 | ||
| Uses | 86 | ||
| Pharmacokinetics | 86 | ||
| Indications and Dosages | 86 | ||
| ► HIV-1 Infection (in combination with other antiretrovirals) | 86 | ||
| PO | 86 | ||
| Adults, Children 13–16 yr. | 86 | ||
| amyl nitrite | 87 | ||
| Category and Schedule | 87 | ||
| Drug Class: | 87 | ||
| Mechanism of Action | 87 | ||
| Uses | 87 | ||
| Pharmacokinetics | 87 | ||
| Indications and Dosages | 87 | ||
| ► Acute Relief of Angina Pectoris | 87 | ||
| Nasal Inhalation | 87 | ||
| Adults, Elderly. | 87 | ||
| Side Effects/Adverse Reactions | 87 | ||
| Frequent | 87 | ||
| Occasional | 88 | ||
| Rare | 88 | ||
| Precautions and Contraindications | 88 | ||
| Drug Interactions of Concern to Dentistry | 88 | ||
| Serious Reactions | 88 | ||
| Dental Considerations | 88 | ||
| General: | 88 | ||
| Consultations: | 88 | ||
| Teach Patient/Family to: | 88 | ||
| anagrelide | 88 | ||
| Category and Schedule | 88 | ||
| Drug Class: | 88 | ||
| Mechanism of Action | 88 | ||
| Uses | 89 | ||
| Pharmacokinetics | 89 | ||
| Indications and Dosages | 89 | ||
| ► Thrombocythemia | 89 | ||
| PO | 89 | ||
| Adults, Elderly. | 89 | ||
| Side Effects/Adverse Reactions | 89 | ||
| Frequent | 89 | ||
| Occasional | 89 | ||
| Rare | 89 | ||
| Precautions and Contraindications | 89 | ||
| Caution: | 89 | ||
| Drug Interactions of Concern to Dentistry | 89 | ||
| Serious Reactions | 89 | ||
| Dental Considerations | 89 | ||
| General: | 89 | ||
| Consultations: | 89 | ||
| Teach Patient/Family to: | 89 | ||
| anakinra | 90 | ||
| Category and Schedule | 90 | ||
| Drug Class: | 90 | ||
| Mechanism of Action | 90 | ||
| Uses | 90 | ||
| Pharmacokinetics | 90 | ||
| Indications and Dosages | 90 | ||
| ► Rheumatoid Arthritis | 90 | ||
| Subcutaneous | 90 | ||
| Adults, Children older than 18 yr, Elderly. | 90 | ||
| Side Effects/Adverse Reactions | 90 | ||
| Occasional | 90 | ||
| Rare | 90 | ||
| Precautions and Contraindications | 90 | ||
| Drug Interactions of Concern to Dentistry | 90 | ||
| Serious Reactions | 90 | ||
| Dental Considerations | 90 | ||
| General: | 90 | ||
| Consultations: | 90 | ||
| Teach Patient/Family to: | 91 | ||
| anastrozole | 91 | ||
| Category and Schedule | 91 | ||
| Drug Class: | 91 | ||
| Mechanism of Action | 91 | ||
| Uses | 91 | ||
| Pharmacokinetics | 91 | ||
| Indications and Dosages | 91 | ||
| ► Breast Cancer | 91 | ||
| PO | 91 | ||
| Adults, Elderly. | 91 | ||
| Side Effects/Adverse Reactions | 91 | ||
| Frequent | 91 | ||
| Occasional | 91 | ||
| Rare | 91 | ||
| Precautions and Contraindications | 91 | ||
| Drug Interactions of Concern to Dentistry | 91 | ||
| Serious Reactions | 91 | ||
| Dental Considerations | 91 | ||
| General: | 91 | ||
| Consultations: | 92 | ||
| Teach Patient/Family to: | 92 | ||
| anidulafungin | 92 | ||
| Category and Schedule | 92 | ||
| Drug Class: | 92 | ||
| Mechanism of Action | 92 | ||
| Uses | 92 | ||
| Pharmacokinetics | 92 | ||
| Indications and Dosages | 92 | ||
| ► Candidemia | 92 | ||
| IV | 92 | ||
| Adults. | 92 | ||
| ► Esophageal Candidiasis | 93 | ||
| IV | 93 | ||
| Adult. | 93 | ||
| Children. | 93 | ||
| Side Effects/Adverse Reactions | 93 | ||
| Rare | 93 | ||
| Precautions and Contraindications | 93 | ||
| Caution: | 93 | ||
| Drug Interactions of Concern to Dentistry | 93 | ||
| Serious Reactions | 93 | ||
| Dental Considerations | 93 | ||
| General: | 93 | ||
| Teach Patient/Family to: | 93 | ||
| apomorphine | 93 | ||
| Category and Schedule | 93 | ||
| Drug Class: | 93 | ||
| Mechanism of Action | 93 | ||
| Uses | 93 | ||
| Pharmacokinetics | 93 | ||
| Indications and Dosages | 94 | ||
| ► Acute, Intermittent Treatment of Hypomobility (“Off Episodes”) Associated with Advanced Parkinson’s Disease | 94 | ||
| Injection Pen for Subcutaneous Administration | 94 | ||
| Adult, Elderly. | 94 | ||
| Side Effects/Adverse Reactions | 94 | ||
| Precautions and Contraindications | 94 | ||
| Drug Interactions of Concern to Dentistry | 94 | ||
| Dental Considerations | 94 | ||
| General: | 94 | ||
| Consultations: | 94 | ||
| Teach Patient/Family to: | 94 | ||
| apraclonidine hydrochloride | 95 | ||
| Category and Schedule | 95 | ||
| Drug Class: | 95 | ||
| Mechanism of Action | 95 | ||
| Uses | 95 | ||
| Pharmacokinetics | 95 | ||
| Indications and Dosages | 95 | ||
| ► Glaucoma | 95 | ||
| apremilast | 96 | ||
| Category and Schedule | 96 | ||
| Drug Class: | 96 | ||
| Mechanism of Action | 96 | ||
| Uses | 96 | ||
| Pharmacokinetics | 96 | ||
| Indications and Dosages | 96 | ||
| ► Active Psoriatic Arthritis or Plaque Psoriasis (Moderate to Severe) | 96 | ||
| PO | 96 | ||
| Adults. | 96 | ||
| Side Effects/Adverse Reactions | 96 | ||
| Frequent | 96 | ||
| Occasional | 96 | ||
| Precautions and Contraindications | 96 | ||
| Drug Interactions of Concern to Dentistry | 97 | ||
| Serious Reactions | 97 | ||
| Dental Considerations | 97 | ||
| General: | 97 | ||
| Teach Patient/Family to: | 97 | ||
| aprepitant | 97 | ||
| Category and Schedule | 97 | ||
| Drug Class: | 97 | ||
| Mechanism of Action | 97 | ||
| Uses | 97 | ||
| Pharmacokinetics | 97 | ||
| Indications and Dosages | 97 | ||
| ► Prevention of Chemotherapy-Induced Nausea and Vomiting | 97 | ||
| PO | 97 | ||
| Adults, Elderly. | 97 | ||
| Side Effects/Adverse Reactions | 97 | ||
| Frequent | 97 | ||
| Occasional | 97 | ||
| Rare | 97 | ||
| Precautions and Contraindications | 98 | ||
| Caution: | 98 | ||
| Drug Interactions of Concern to Dentistry | 98 | ||
| Serious Reactions | 98 | ||
| Dental Considerations | 98 | ||
| General: | 98 | ||
| Consultations: | 98 | ||
| Teach Patient/Family to: | 98 | ||
| arformoterol tartrate | 99 | ||
| Category and Schedule | 99 | ||
| Drug Class: | 99 | ||
| Mechanism of Action | 99 | ||
| Uses | 99 | ||
| Pharmacokinetics | 99 | ||
| Indications and Dosages | 99 | ||
| ► COPD | 99 | ||
| Oral Inhalation | 99 | ||
| Adults. | 99 | ||
| Children. | 99 | ||
| Side Effects/Adverse Reactions | 99 | ||
| Occasional | 99 | ||
| Rare | 99 | ||
| Precautions and Contraindications | 99 | ||
| Caution: | 99 | ||
| Drug Interactions of Concern to Dentistry | 99 | ||
| Serious Reactions | 99 | ||
| Dental Considerations | 99 | ||
| General: | 99 | ||
| Consultations: | 100 | ||
| Teach Patient/Family to: | 100 | ||
| aripiprazole | 100 | ||
| Category and Schedule | 100 | ||
| Drug Class: | 100 | ||
| Mechanism of Action | 100 | ||
| Uses | 100 | ||
| Pharmacokinetics | 100 | ||
| Indications and Dosages | 100 | ||
| ► Schizophrenia, Bipolar Disorder | 100 | ||
| PO | 100 | ||
| Adults, Elderly. | 100 | ||
| Side Effects/Adverse Reactions | 100 | ||
| Frequent | 100 | ||
| Occasional | 100 | ||
| Rare | 100 | ||
| Precautions and Contraindications | 100 | ||
| Caution: | 100 | ||
| Drug Interactions of Concern to Dentistry | 100 | ||
| Serious Reactions | 101 | ||
| Dental Considerations | 101 | ||
| General: | 101 | ||
| Consultations: | 101 | ||
| Teach Patient/Family to: | 101 | ||
| armodafinil | 101 | ||
| Category and Schedule | 101 | ||
| Drug Class: | 101 | ||
| Mechanism of Action | 101 | ||
| Uses | 101 | ||
| Pharmacokinetics | 101 | ||
| Indications and Dosages | 101 | ||
| ► Narcolepsy, Improve Wakefulness in Patients with Excessive Sleepiness; Obstructive Sleep Apnea | 101 | ||
| artemether/lumefantrine | 102 | ||
| Category and Schedule | 102 | ||
| Drug Class: | 102 | ||
| Mechanism of Action | 102 | ||
| Uses | 103 | ||
| Pharmacokinetics | 103 | ||
| Indications and Dosages | 103 | ||
| ► Malaria due to Plasmodium falciparum | 103 | ||
| PO | 103 | ||
| Adults, 16 yr and older (who weigh 35 kg or greater). | 103 | ||
| Children younger than 16 yr old who weigh 25 to less than 35 kg. | 103 | ||
| Children younger than 16 yr old who weigh 15 to less than 25 kg. | 103 | ||
| Children younger than 16 yr old who weigh 5 to less than 15 kg. | 103 | ||
| Side Effects/Adverse Reactions | 103 | ||
| Frequent | 103 | ||
| Occasional | 103 | ||
| Rare | 103 | ||
| Precautions and Contraindications | 103 | ||
| Caution: | 103 | ||
| Drug Interactions of Concern to Dentistry | 104 | ||
| Serious Reactions | 104 | ||
| Dental Considerations | 104 | ||
| General: | 104 | ||
| Consultations: | 104 | ||
| Teach Patient/Family to: | 104 | ||
| articaine hydrochloride | 105 | ||
| Category and Schedule | 105 | ||
| Drug Class: | 105 | ||
| Mechanism of Action | 105 | ||
| Uses | 105 | ||
| Pharmacokinetics | 105 | ||
| Indications and Dosages | 105 | ||
| ► Local, Infiltrative, or Conductive Anesthesia in Both Simple and Complex Dental or Periodontal Procedures | 105 | ||
| Infiltration | 105 | ||
| Adults, Elderly, Children older than 4 yr. | 105 | ||
| Side Effects/Adverse Reactions | 105 | ||
| Rare | 105 | ||
| Precautions and Contraindications | 105 | ||
| Caution: | 105 | ||
| Drug Interactions of Concern to Dentistry | 105 | ||
| Serious Reactions | 106 | ||
| Dental Considerations | 106 | ||
| General: | 106 | ||
| Teach Patient/Family to: | 106 | ||
| asenapine | 106 | ||
| Category and Schedule | 106 | ||
| Drug Class: | 106 | ||
| Mechanism of Action | 106 | ||
| Uses | 106 | ||
| Pharmacokinetics | 106 | ||
| Indications and Dosages | 107 | ||
| ► Schizophrenia | 107 | ||
| aspirin/acetylsalicylic acid | 108 | ||
| Category and Schedule | 108 | ||
| Drug Class: | 108 | ||
| Mechanism of Action | 108 | ||
| Uses | 108 | ||
| Pharmacokinetics | 108 | ||
| Indications and Dosages | 108 | ||
| ► Analgesia, Fever | 108 | ||
| PO, Rectal | 108 | ||
| atazanavir + cobicistat | 110 | ||
| Category and Schedule | 110 | ||
| Drug Class: | 110 | ||
| Mechanism of Action | 110 | ||
| Uses | 110 | ||
| Pharmacokinetics | 110 | ||
| Indications and Dosages | 111 | ||
| ► HIV-1 Infection (treatment-naive or treatment-experienced) | 111 | ||
| PO | 111 | ||
| Adults. | 111 | ||
| Side Effects/Adverse Reactions | 111 | ||
| Frequent | 111 | ||
| Occasional | 111 | ||
| Precautions and Contraindications | 111 | ||
| Drug Interactions of Concern to Dentistry | 111 | ||
| Serious Reactions | 111 | ||
| Dental Considerations | 112 | ||
| General: | 112 | ||
| Consultations: | 112 | ||
| Teach Patient/Family to: | 112 | ||
| atazanavir sulfate | 112 | ||
| Category and Schedule | 112 | ||
| Drug Class: | 112 | ||
| Mechanism of Action | 112 | ||
| Uses | 112 | ||
| Pharmacokinetics | 112 | ||
| Indications and Dosages | 112 | ||
| ► HIV-1 Infection | 112 | ||
| atenolol | 114 | ||
| Category and Schedule | 114 | ||
| Drug Class: | 114 | ||
| Mechanism of Action | 114 | ||
| Uses | 114 | ||
| Pharmacokinetics | 114 | ||
| Indications and Dosages | 114 | ||
| ► Hypertension | 114 | ||
| atomoxetine | 116 | ||
| Category and Schedule | 116 | ||
| Drug Class: | 116 | ||
| Mechanism of Action | 116 | ||
| Uses | 116 | ||
| Pharmacokinetics | 116 | ||
| Indications and Dosages | 116 | ||
| ► ADHD | 116 | ||
| PO | 116 | ||
| Adults, Children weighing 70 kg and more. | 116 | ||
| Children weighing less than 70 kg. | 116 | ||
| ► Dosage in Hepatic Impairment | 116 | ||
| Side Effects/Adverse Reactions | 116 | ||
| Frequent | 116 | ||
| Occasional | 116 | ||
| Rare | 117 | ||
| Precautions and Contraindications | 117 | ||
| Caution: | 117 | ||
| Drug Interactions of Concern to Dentistry | 117 | ||
| Serious Reactions | 117 | ||
| Dental Considerations | 117 | ||
| General: | 117 | ||
| Consultations: | 117 | ||
| Teach Patient/Family to: | 117 | ||
| atorvastatin | 117 | ||
| Category and Schedule | 117 | ||
| Drug Class: | 117 | ||
| Mechanism of Action | 117 | ||
| Uses | 118 | ||
| Pharmacokinetics | 118 | ||
| Indications and Dosages | 118 | ||
| ► Hyperlipidemia, Reduction of Risk of MI, Angina Revascularization Procedures | 118 | ||
| atropine sulfate | 118 | ||
| Category and Schedule | 118 | ||
| Drug Class: | 118 | ||
| Mechanism of Action | 119 | ||
| Uses | 119 | ||
| Pharmacokinetics | 119 | ||
| Indications and Dosages | 119 | ||
| ► Asystole, Slow, Pulseless Electrical Activity | 119 | ||
| aurothioglucose/gold sodium thiomalate | 120 | ||
| Category and Schedule | 120 | ||
| Drug Class: | 120 | ||
| Mechanism of Action | 120 | ||
| Uses | 120 | ||
| Pharmacokinetics | 120 | ||
| Indications and Dosages | 121 | ||
| ► Rheumatoid Arthritis (Aurothioglucose) | 121 | ||
| avanafil | 122 | ||
| Category and Schedule | 122 | ||
| Drug Class: | 122 | ||
| Mechanism of Action | 122 | ||
| Uses | 122 | ||
| Pharmacokinetics | 122 | ||
| Indications and Dosages | 122 | ||
| ► Erectile Dysfunction | 122 | ||
| PO | 122 | ||
| Adults. | 122 | ||
| Side Effects/Adverse Reactions | 123 | ||
| Frequent | 123 | ||
| Occasional | 123 | ||
| Precautions and Contraindications | 123 | ||
| Drug Interactions of Concern to Dentistry | 123 | ||
| Serious Reactions | 123 | ||
| Dental Considerations | 123 | ||
| General: | 123 | ||
| Teach Patient/Family to: | 123 | ||
| axitinib | 123 | ||
| Category and Schedule | 123 | ||
| Drug Class: | 123 | ||
| Mechanism of Action | 123 | ||
| Uses | 123 | ||
| Pharmacokinetics | 123 | ||
| Indications and Dosages | 124 | ||
| ► Renal Cell Cancer, Advanced | 124 | ||
| PO | 124 | ||
| Adults. | 124 | ||
| Side Effects/Adverse Reactions | 124 | ||
| Frequent | 124 | ||
| Occasional | 124 | ||
| Precautions and Contraindications | 124 | ||
| Drug Interactions of Concern to Dentistry | 124 | ||
| Serious Reactions | 124 | ||
| Dental Considerations | 124 | ||
| General: | 124 | ||
| Consultations: | 124 | ||
| Teach Patient/Family to: | 125 | ||
| azatadine maleate | 125 | ||
| Category and Schedule | 125 | ||
| Drug Class: | 125 | ||
| Mechanism of Action | 125 | ||
| Uses | 125 | ||
| Pharmacokinetics | 125 | ||
| Indications and Dosages | 125 | ||
| ► Allergic Rhinitis | 125 | ||
| PO | 125 | ||
| Adults, Elderly, Children 12 yr or older. | 125 | ||
| Side Effects/Adverse Reactions | 125 | ||
| Frequent | 125 | ||
| Rare | 125 | ||
| Precautions and Contraindications | 125 | ||
| Drug Interactions of Concern to Dentistry | 125 | ||
| Serious Reactions | 125 | ||
| Dental Considerations | 125 | ||
| General: | 125 | ||
| Consultations: | 126 | ||
| Teach Patient/Family to: | 126 | ||
| azathioprine | 126 | ||
| Category and Schedule | 126 | ||
| Drug Class: | 126 | ||
| Mechanism of Action | 126 | ||
| Uses | 126 | ||
| Pharmacokinetics | 126 | ||
| Indications and Dosages | 126 | ||
| ► Adjunct in Prevention of Renal Allograft Rejection | 126 | ||
| PO, IV | 126 | ||
| Adults, Elderly, Children. | 126 | ||
| ► Rheumatoid Arthritis | 126 | ||
| PO | 126 | ||
| Adults. | 126 | ||
| Elderly. | 127 | ||
| ► Dosage in Renal Impairment | 127 | ||
| Side Effects/Adverse Reactions | 127 | ||
| Frequent | 127 | ||
| Occasional | 127 | ||
| Rare | 127 | ||
| Precautions and Contraindications | 127 | ||
| Drug Interactions of Concern to Dentistry | 127 | ||
| Serious Reactions | 127 | ||
| Dental Considerations | 127 | ||
| General: | 127 | ||
| Consultations: | 127 | ||
| Teach Patient/Family to: | 127 | ||
| azelastine | 127 | ||
| Category and Schedule | 127 | ||
| Drug Class: | 127 | ||
| Mechanism of Action | 128 | ||
| Uses | 128 | ||
| Pharmacokinetics | 128 | ||
| Indications and Dosages | 128 | ||
| ► Allergic Rhinitis | 128 | ||
| Nasal | 128 | ||
| Adults, Elderly, Children 12 yr and older. | 128 | ||
| Children 5–11 yr. | 128 | ||
| ► Allergic Conjunctivitis | 128 | ||
| Ophthalmic | 128 | ||
| Adults, Elderly, Children 3 yr or older. | 128 | ||
| Side Effects/Adverse Reactions | 128 | ||
| Frequent | 128 | ||
| Rare | 128 | ||
| Precautions and Contraindications | 128 | ||
| Drug Interactions of Concern to Dentistry | 128 | ||
| Serious Reactions | 128 | ||
| Dental Considerations | 128 | ||
| General: | 128 | ||
| Teach Patient/Family: | 128 | ||
| azilsartan medoxomil | 129 | ||
| Category and Schedule | 129 | ||
| Drug Class: | 129 | ||
| Mechanism of Action | 129 | ||
| Uses | 129 | ||
| Pharmacokinetics | 129 | ||
| Indications and Dosages | 129 | ||
| ► Hypertension | 129 | ||
| PO | 129 | ||
| Adults. | 129 | ||
| Side Effects/Adverse Reactions | 129 | ||
| Frequent | 129 | ||
| Occasional | 129 | ||
| Precautions and Contraindications | 129 | ||
| Drug Interactions of Concern to Dentistry | 129 | ||
| Serious Reactions | 129 | ||
| Dental Considerations | 130 | ||
| General: | 130 | ||
| Consultations: | 130 | ||
| Teach Patient/Family to: | 130 | ||
| azithromycin | 130 | ||
| Category and Schedule | 130 | ||
| Drug Class: | 130 | ||
| Mechanism of Action | 130 | ||
| Uses | 130 | ||
| Pharmacokinetics | 130 | ||
| Indications and Dosages | 131 | ||
| ► Respiratory Tract, Skin, and Skin-Structure Infections | 131 | ||
| aztreonam | 132 | ||
| Category and Schedule | 132 | ||
| Drug Class: | 132 | ||
| Mechanism of Action | 132 | ||
| Uses | 132 | ||
| Pharmacokinetics | 132 | ||
| Indications and Dosages | 132 | ||
| ► UTIs | 132 | ||
| bacitracin | 134 | ||
| Category and Schedule | 134 | ||
| Drug Class: | 134 | ||
| Mechanism of Action | 134 | ||
| Uses | 134 | ||
| Indications and Dosages | 134 | ||
| ► Superficial Ocular Infections | 134 | ||
| Ophthalmic | 134 | ||
| Adults. | 134 | ||
| ► Skin Abrasions, Superficial Skin Infections | 134 | ||
| Topical | 134 | ||
| Adults, Children. | 134 | ||
| ► Surgical Treatment and Prophylaxis | 134 | ||
| Irrigation | 134 | ||
| Adults, Elderly. | 134 | ||
| Side Effects/Adverse Reactions | 134 | ||
| Rare | 134 | ||
| Precautions and Contraindications | 134 | ||
| Drug Interactions of Concern to Dentistry | 134 | ||
| Serious Reactions | 134 | ||
| Dental Considerations | 134 | ||
| General: | 134 | ||
| Teach Patient/Family to: | 134 | ||
| Mechanism of Action | 135 | ||
| Uses | 135 | ||
| Pharmacokinetics | 135 | ||
| Indications and Dosages | 135 | ||
| ► Spasticity | 135 | ||
| PO | 135 | ||
| Adults. | 135 | ||
| Elderly. | 135 | ||
| Children. | 135 | ||
| Usual Intrathecal Dosage | 135 | ||
| Adults, Elderly, Children older than 12 yr. | 135 | ||
| Children 12 yr and younger. | 135 | ||
| Side Effects/Adverse Reactions | 135 | ||
| Frequent | 135 | ||
| Occasional | 135 | ||
| Rare | 135 | ||
| Precautions and Contraindications | 135 | ||
| Drug Interactions of Concern To Dentistry | 135 | ||
| Serious Reactions | 135 | ||
| Dental Considerations | 135 | ||
| General: | 135 | ||
| Teach Patient/Family: | 136 | ||
| baclofen | 134 | ||
| balsalazide | 136 | ||
| Category and Schedule | 136 | ||
| Drug Class: | 136 | ||
| Mechanism of Action | 136 | ||
| Uses | 136 | ||
| Pharmacokinetics | 136 | ||
| Indications and Dosages | 136 | ||
| ► Ulcerative Colitis | 136 | ||
| PO | 136 | ||
| Adults, Elderly. | 136 | ||
| Side Effects/Adverse Reactions | 136 | ||
| Frequent | 136 | ||
| Occasional | 136 | ||
| Precautions and Contraindications | 136 | ||
| Drug Interactions of Concern to Dentistry | 136 | ||
| Serious Reactions | 136 | ||
| Dental Considerations | 136 | ||
| General: | 136 | ||
| Consultations: | 136 | ||
| becaplermin | 137 | ||
| Category and Schedule | 137 | ||
| Drug Class: | 137 | ||
| Mechanism of Action | 137 | ||
| Uses | 137 | ||
| Pharmacokinetics | 137 | ||
| Indications and Dosages | 137 | ||
| ► Ulcers | 137 | ||
| Topical | 137 | ||
| Adults, Elderly. | 137 | ||
| Side Effects/Adverse Reactions | 137 | ||
| Occasional | 137 | ||
| Precautions and Contraindications | 137 | ||
| Caution: | 137 | ||
| Drug Interactions of Concern to Dentistry | 137 | ||
| Serious Reactions | 137 | ||
| Dental Considerations | 137 | ||
| General: | 137 | ||
| Consultations: | 137 | ||
| Teach Patient/Family to: | 137 | ||
| beclomethasone dipropionate/beclomethasone dipropionate hfa | 138 | ||
| Category and Schedule | 138 | ||
| Drug Class: | 138 | ||
| Mechanism of Action | 138 | ||
| Uses | 138 | ||
| Pharmacokinetics | 138 | ||
| Indications and Dosages | 138 | ||
| Oral Inhalation (QVAR only) | 138 | ||
| Adults, Adolescents. | 138 | ||
| Children 5–11 yr. | 138 | ||
| Nasal Inhalation | 138 | ||
| benazepril | 139 | ||
| Category and Schedule | 139 | ||
| Drug Class: | 139 | ||
| Mechanism of Action | 139 | ||
| Uses | 139 | ||
| Pharmacokinetics | 139 | ||
| Indications and Dosages | 139 | ||
| ► Hypertension (monotherapy) | 139 | ||
| PO | 139 | ||
| Adults. | 139 | ||
| Elderly. | 140 | ||
| ► Hypertension (combination therapy) | 140 | ||
| PO | 140 | ||
| Adults. | 140 | ||
| ► Dosage in Renal Impairment | 140 | ||
| Side Effects/Adverse Reactions | 140 | ||
| Frequent | 140 | ||
| Occasional | 140 | ||
| Rare | 140 | ||
| Precautions and Contraindications | 140 | ||
| Caution: | 140 | ||
| Drug Interactions of Concern to Dentistry | 140 | ||
| Serious Reactions | 140 | ||
| Dental Considerations | 140 | ||
| General: | 140 | ||
| Consultations: | 141 | ||
| Teach Patient/Family to: | 141 | ||
| bendamustine | 141 | ||
| Category and Schedule | 141 | ||
| Drug Class: | 141 | ||
| Mechanism of Action | 141 | ||
| Uses | 141 | ||
| Pharmacokinetics | 141 | ||
| Indications and Dosages | 141 | ||
| IV | 141 | ||
| Adult. | 141 | ||
| Pediatric Dosing. | 141 | ||
| Dose Adjustments. | 141 | ||
| Side Effects/Adverse Reactions | 142 | ||
| Frequent | 142 | ||
| Occasional | 142 | ||
| Precautions and Contraindications | 142 | ||
| Drug Interactions of Concern to Dentistry | 142 | ||
| Serious Reactions | 142 | ||
| Dental Considerations | 142 | ||
| General: | 142 | ||
| Consultations: | 142 | ||
| Teach Patient/Family to: | 142 | ||
| bendroflumethiazide | 143 | ||
| Category and Schedule | 143 | ||
| Drug Class: | 143 | ||
| Mechanism of Action | 143 | ||
| Uses | 143 | ||
| Pharmacokinetics | 143 | ||
| Indications and Dosages | 143 | ||
| ► Edema | 143 | ||
| benzocaine | 144 | ||
| Category and Schedule | 144 | ||
| Drug Class: | 144 | ||
| Mechanism of Action | 145 | ||
| Uses | 145 | ||
| Pharmacokinetics | 145 | ||
| Indications and Dosages | 145 | ||
| ► Canker Sores | 145 | ||
| benzonatate | 146 | ||
| Category and Schedule | 146 | ||
| Drug Class: | 146 | ||
| Mechanism of Action | 146 | ||
| Uses | 146 | ||
| Pharmacokinetics | 146 | ||
| Indications and Dosages | 146 | ||
| ► Antitussive | 146 | ||
| PO | 146 | ||
| Adults, Elderly, Children older than 10 yr. | 146 | ||
| Side Effects/Adverse Reactions | 146 | ||
| Occasional | 146 | ||
| Precautions and Contraindications | 146 | ||
| Caution: | 146 | ||
| Drug Interactions of Concern to Dentistry | 146 | ||
| Serious Reactions | 146 | ||
| Dental Considerations | 146 | ||
| General: | 146 | ||
| Uses | 147 | ||
| Pharmacokinetics | 147 | ||
| Indications and Dosages | 147 | ||
| ► Edema | 147 | ||
| benzthiazide | 146 | ||
| benztropine mesylate | 148 | ||
| Category and Schedule | 148 | ||
| Drug Class: | 148 | ||
| Mechanism of Action | 148 | ||
| Uses | 148 | ||
| Pharmacokinetics | 148 | ||
| Indications and Dosages | 148 | ||
| ► Parkinsonism | 148 | ||
| PO | 148 | ||
| bepridil | 149 | ||
| Category and Schedule | 149 | ||
| Drug Class: | 149 | ||
| Mechanism of Action | 150 | ||
| Uses | 150 | ||
| Pharmacokinetics | 150 | ||
| Indications and Dosages | 150 | ||
| ► Chronic Stable Angina | 150 | ||
| PO | 150 | ||
| Adults, Elderly. | 150 | ||
| Side Effects/Adverse Reactions | 150 | ||
| Frequent | 150 | ||
| Occasional | 150 | ||
| Rare | 150 | ||
| Precautions and Contraindications | 150 | ||
| Caution: | 150 | ||
| Drug Interactions of Concern to Dentistry | 150 | ||
| Serious Reactions | 150 | ||
| Dental Considerations | 150 | ||
| General: | 150 | ||
| Consultations: | 151 | ||
| Teach Patient/Family to: | 151 | ||
| besifloxacin | 151 | ||
| Category and Schedule | 151 | ||
| Drug Class: | 151 | ||
| Mechanism of Action | 151 | ||
| Uses | 151 | ||
| Pharmacokinetics | 151 | ||
| Indications and Dosages | 151 | ||
| ► Conjunctivitis | 151 | ||
| Adults, Children over 1 yr. | 151 | ||
| Side Effects/Adverse Reactions | 151 | ||
| Frequent | 151 | ||
| Occasional | 151 | ||
| Precautions and Contraindications | 151 | ||
| Drug Interactions of Concern to Dentistry | 151 | ||
| Serious Reactions | 151 | ||
| Dental Considerations | 151 | ||
| General: | 151 | ||
| betamethasone | 152 | ||
| Category and Schedule | 152 | ||
| Drug Class: | 152 | ||
| Mechanism of Action | 152 | ||
| Uses | 152 | ||
| Pharmacokinetics | 152 | ||
| Indications and Dosages | 152 | ||
| ► Antiinflammation, Immunosuppression, Corticosteroid Replacement Therapy | 152 | ||
| PO | 152 | ||
| betaxolol | 153 | ||
| Category and Schedule | 153 | ||
| Drug Class: | 153 | ||
| Mechanism of Action | 153 | ||
| Uses | 153 | ||
| Pharmacokinetics | 153 | ||
| Indications and Dosages | 153 | ||
| ► Hypertension | 153 | ||
| PO | 153 | ||
| Adults. | 153 | ||
| Elderly. | 153 | ||
| ► Chronic Open-Angle Glaucoma and Ocular Hypertension | 153 | ||
| Ophthalmic (Eye Drops) | 153 | ||
| Adults, Elderly. | 153 | ||
| ► Dosage in Renal Impairment | 154 | ||
| Side Effects/Adverse Reactions | 154 | ||
| Frequent | 154 | ||
| Occasional | 154 | ||
| Rare | 154 | ||
| Precautions and Contraindications | 154 | ||
| Caution: | 154 | ||
| Drug Interactions of Concern to Dentistry | 154 | ||
| Serious Reactions | 154 | ||
| Dental Considerations | 154 | ||
| General: | 154 | ||
| Consultations: | 155 | ||
| Teach Patient/Family to: | 155 | ||
| bethanechol chloride | 155 | ||
| Category and Schedule | 155 | ||
| Drug Class: | 155 | ||
| Mechanism of Action | 155 | ||
| Uses | 155 | ||
| Pharmacokinetics | 155 | ||
| Indications and Dosages | 155 | ||
| ► Postoperative and Postpartum Urine Retention, Atony of Bladder | 155 | ||
| PO | 155 | ||
| Adults, Elderly. | 155 | ||
| Children. | 155 | ||
| Side Effects/Adverse Reactions | 155 | ||
| Occasional | 155 | ||
| Precautions and Contraindications | 155 | ||
| Caution: | 156 | ||
| Drug Interactions of Concern to Dentistry | 156 | ||
| Serious Reactions | 156 | ||
| Dental Considerations | 156 | ||
| General: | 156 | ||
| Consultations: | 156 | ||
| bevacizumab | 156 | ||
| Category and Schedule | 156 | ||
| Drug Class: | 156 | ||
| Mechanism of Action | 156 | ||
| Uses | 156 | ||
| Pharmacokinetics | 156 | ||
| Indications and Dosages | 156 | ||
| ► First-Line Treatment of Metastatic Carcinoma of the Colon or Rectum in Combination with 5-Fluorouracil (5-FU) | 156 | ||
| IV | 156 | ||
| Adults, Elderly. | 156 | ||
| Side Effects/Adverse Reactions | 156 | ||
| Frequent | 156 | ||
| Occasional | 156 | ||
| Rare | 156 | ||
| Precautions and Contraindications | 156 | ||
| Drug Interactions of Concern to Dentistry | 157 | ||
| Serious Reactions | 157 | ||
| Dental Considerations | 157 | ||
| General: | 157 | ||
| Consultations: | 157 | ||
| Teach Patient/Family to: | 157 | ||
| bexarotene | 158 | ||
| Category and Schedule | 158 | ||
| Drug Class: | 158 | ||
| Mechanism of Action | 158 | ||
| Uses | 158 | ||
| Pharmacokinetics | 158 | ||
| Indications and Dosages | 158 | ||
| ► Cutaneous T-Cell Lymphoma Refractory to at Least One Prior Systemic Therapy | 158 | ||
| PO | 158 | ||
| bicalutamide | 159 | ||
| Category and Schedule | 159 | ||
| Drug Class: | 159 | ||
| Mechanism of Action | 159 | ||
| Uses | 159 | ||
| Pharmacokinetics | 159 | ||
| Indications and Dosages | 159 | ||
| ► Prostatic Carcinoma | 159 | ||
| PO | 159 | ||
| Adults, Elderly. | 159 | ||
| Side Effects/Adverse Reactions | 159 | ||
| Frequent | 159 | ||
| Occasional | 159 | ||
| Rare | 159 | ||
| Precautions and Contraindications | 159 | ||
| Caution: | 159 | ||
| Drug Interactions of Concern to Dentistry | 159 | ||
| Serious Reactions | 159 | ||
| Dental Considerations | 159 | ||
| General: | 159 | ||
| Consultations: | 160 | ||
| Teach Patient/Family to: | 160 | ||
| bimatoprost | 160 | ||
| Category and Schedule | 160 | ||
| Drug Class: | 160 | ||
| Mechanism of Action | 160 | ||
| Uses | 160 | ||
| Pharmacokinetics | 160 | ||
| Indications and Dosages | 160 | ||
| ► Glaucoma, Ocular Hypertension | 160 | ||
| Ophthalmic | 160 | ||
| Adults, Elderly. | 160 | ||
| Side Effects/Adverse Reactions | 160 | ||
| Frequent | 160 | ||
| Occasional | 160 | ||
| Rare | 160 | ||
| Precautions and Contraindications | 161 | ||
| Caution: | 161 | ||
| Drug Interactions of Concern to Dentistry | 161 | ||
| Serious Reactions | 161 | ||
| Dental Considerations | 161 | ||
| General: | 161 | ||
| Consultations: | 161 | ||
| Teach Patient/Family to: | 161 | ||
| biperiden | 161 | ||
| Category and Schedule | 161 | ||
| Drug Class: | 161 | ||
| Mechanism of Action | 161 | ||
| Uses | 161 | ||
| Pharmacokinetics | 161 | ||
| Indications and Dosages | 161 | ||
| ► Extrapyramidal Symptoms | 161 | ||
| bismuth subsalicylate | 162 | ||
| Category and Schedule | 162 | ||
| Drug Class: | 162 | ||
| Mechanism of Action | 162 | ||
| Uses | 163 | ||
| Pharmacokinetics | 163 | ||
| Indications and Dosages | 163 | ||
| ► Diarrhea, Gastric Distress | 163 | ||
| bisoprolol fumarate | 163 | ||
| Category and Schedule | 163 | ||
| Drug Class: | 163 | ||
| Mechanism of Action | 163 | ||
| Uses | 164 | ||
| Pharmacokinetics | 164 | ||
| Indications and Dosages | 164 | ||
| ► Hypertension | 164 | ||
| PO | 164 | ||
| Adults. | 164 | ||
| Elderly. | 164 | ||
| ► Dosage in Hepatic Impairment | 164 | ||
| Side Effects/Adverse Reactions | 164 | ||
| Frequent | 164 | ||
| Occasional | 164 | ||
| Rare | 164 | ||
| Precautions and Contraindications | 164 | ||
| Caution: | 164 | ||
| Drug Interactions of Concern to Dentistry | 164 | ||
| Serious Reactions | 164 | ||
| Dental Considerations | 164 | ||
| General: | 164 | ||
| Consultations: | 165 | ||
| Teach Patient/Family to: | 165 | ||
| bivalirudin | 165 | ||
| Category and Schedule | 165 | ||
| Drug Class: | 165 | ||
| Mechanism of Action | 165 | ||
| Uses | 165 | ||
| Pharmacokinetics | 165 | ||
| Indications and Dosages | 165 | ||
| ► Anticoagulant in Patients with Unstable Angina Who Are Undergoing Percutaneous Transluminal Coronary Angioplasty (PTCA) in Conjunction with Aspirin | 165 | ||
| IV | 165 | ||
| Adults, Elderly. | 165 | ||
| Dosage in Renal Impairment | 166 | ||
| Side Effects/Adverse Reactions | 166 | ||
| Frequent | 166 | ||
| Occasional | 166 | ||
| Rare | 166 | ||
| Precautions and Contraindications | 166 | ||
| Drug Interactions of Concern To Dentistry | 166 | ||
| Serious Reactions | 166 | ||
| Dental Considerations | 166 | ||
| General: | 166 | ||
| Consultations: | 166 | ||
| Teach Patient/Family to: | 166 | ||
| bleomycin sulfate | 166 | ||
| Category and Schedule | 166 | ||
| Drug Class: | 166 | ||
| Mechanism of Action | 166 | ||
| Uses | 167 | ||
| Pharmacokinetics | 167 | ||
| Indications and Dosages | 167 | ||
| ► As Monotherapy to Treat Testicular Carcinoma; Lymphomas (Including Hodgkin’s Disease, Choriocarcinoma, Reticulum Cell Sarcoma, and Lymphosarcoma); and Squamous Cell Carcinomas of the Head and Neck (Including Mouth, Tongue, Tonsil, Nasopharynx, Oropharynx, Sinus, Palate, Lip, Buccal Mucosa, Gingiva, Epiglottis, and Larynx) | 167 | ||
| IV, IM, Subcutaneous | 167 | ||
| boceprevir | 168 | ||
| Category and Schedule | 168 | ||
| Drug Class: | 168 | ||
| Mechanism of Action | 168 | ||
| Uses | 168 | ||
| Pharmacokinetics | 168 | ||
| Indications and Dosages | 169 | ||
| ► Treatment of Chronic Hepatitis C (CHC) | 169 | ||
| PO | 169 | ||
| Adults. | 169 | ||
| Side Effects/Adverse Reactions | 169 | ||
| Frequent | 169 | ||
| Occasional | 169 | ||
| Precautions and Contraindications | 169 | ||
| Drug Interactions of Concern to Dentistry | 169 | ||
| Serious Reactions | 169 | ||
| Dental Considerations | 169 | ||
| General: | 169 | ||
| Consultations: | 169 | ||
| Teach Patient/Family to: | 169 | ||
| bosentan | 169 | ||
| Category and Schedule | 169 | ||
| Drug Class: | 169 | ||
| Mechanism of Action | 170 | ||
| Uses | 170 | ||
| Pharmacokinetics | 170 | ||
| Indications and Dosages | 170 | ||
| ► PAH in Those with WHO Class III or IV Symptoms | 170 | ||
| PO | 170 | ||
| Adults, Elderly. | 170 | ||
| Children weighing less than 40 kg. | 170 | ||
| Side Effects/Adverse Reactions | 170 | ||
| Occasional | 170 | ||
| Rare | 170 | ||
| Precautions and Contraindications | 170 | ||
| Caution: | 170 | ||
| Drug Interactions of Concern to Dentistry | 170 | ||
| Serious Reactions | 170 | ||
| Dental Considerations | 170 | ||
| General: | 170 | ||
| Teach Patient/Family to: | 170 | ||
| brexpiprazole | 171 | ||
| Category and Schedule | 171 | ||
| Drug Class: | 171 | ||
| Mechanism of Action | 171 | ||
| Uses | 171 | ||
| Pharmacokinetics | 171 | ||
| Indications and Dosages | 171 | ||
| ► Major Depressive Disorder (Adjunct to Antidepressants) | 171 | ||
| brimonidine | 172 | ||
| Category and Schedule | 172 | ||
| Drug Class: | 172 | ||
| Mechanism of Action | 172 | ||
| Uses | 172 | ||
| Pharmacokinetics | 172 | ||
| Indications and Dosages | 172 | ||
| ► Glaucoma, Ocular Hypertension | 172 | ||
| Ophthalmic | 172 | ||
| Adults, Elderly, Children 2 yr and older. | 172 | ||
| Side Effects/Adverse Reactions | 173 | ||
| Occasional | 173 | ||
| Precautions and Contraindications | 173 | ||
| Caution: | 173 | ||
| Drug Interactions of Concern to Dentistry | 173 | ||
| Serious Reactions | 173 | ||
| Dental Considerations | 173 | ||
| General: | 173 | ||
| Consultations: | 173 | ||
| Teach Patient/Family to: | 173 | ||
| brinzolamide | 173 | ||
| Category and Schedule | 173 | ||
| Drug Class: | 173 | ||
| bromocriptine mesylate | 174 | ||
| Category and Schedule | 174 | ||
| Drug Class: | 174 | ||
| Mechanism of Action | 174 | ||
| Uses | 174 | ||
| Pharmacokinetics | 174 | ||
| Indications and Dosages | 174 | ||
| ► Glaucoma, Ocular Hypertension | 174 | ||
| Ophthalmic | 174 | ||
| Adults, Elderly. | 174 | ||
| Side Effects/Adverse Reactions | 174 | ||
| Occasional | 174 | ||
| Rare | 174 | ||
| Precautions and Contraindications | 174 | ||
| Caution: | 174 | ||
| Drug Interactions of Concern to Dentistry | 174 | ||
| Serious Reactions | 174 | ||
| Dental Considerations | 174 | ||
| General: | 174 | ||
| Consultations: | 174 | ||
| Uses | 175 | ||
| Pharmacokinetics | 175 | ||
| Indications and Dosages | 175 | ||
| ► Hyperprolactinemia | 175 | ||
| brompheniramine | 176 | ||
| Category and Schedule | 176 | ||
| Drug Class: | 176 | ||
| Mechanism of Action | 176 | ||
| Uses | 176 | ||
| Pharmacokinetics | 176 | ||
| Indications and Dosages | 176 | ||
| ► Allergic Rhinitis, Anaphylaxis, Urticarial Transfusion Reactions, Urticaria | 176 | ||
| PO | 176 | ||
| bucindolol | 177 | ||
| Drug Class: | 177 | ||
| Mechanism of Action | 177 | ||
| Uses | 177 | ||
| Pharmacokinetics | 177 | ||
| Indications and Dosages | 177 | ||
| ► Hypertension | 177 | ||
| PO | 177 | ||
| Adults. | 177 | ||
| ► Congestive Heart Failure | 178 | ||
| PO | 178 | ||
| Adults. | 178 | ||
| Side Effects/Adverse Reactions | 178 | ||
| Frequent | 178 | ||
| Occasional | 178 | ||
| Rare | 178 | ||
| Precautions and Contraindications | 178 | ||
| Caution: | 178 | ||
| Drug Interactions of Concern to Dentistry | 178 | ||
| Serious Reactions | 178 | ||
| Dental Considerations | 178 | ||
| General: | 178 | ||
| Consultations: | 179 | ||
| Teach Patient/Family to: | 179 | ||
| buclizine hydrochloride | 179 | ||
| Category and Schedule | 179 | ||
| Drug Class: | 179 | ||
| Mechanism of Action | 179 | ||
| Uses | 179 | ||
| Pharmacokinetics | 179 | ||
| Indications and Dosages | 179 | ||
| ► Motion Sickness | 179 | ||
| PO | 179 | ||
| Adults, Elderly, Children 12 yr and older. | 179 | ||
| Side Effects/Adverse Reactions | 179 | ||
| Frequent | 179 | ||
| Occasional | 179 | ||
| Precautions and Contraindications | 179 | ||
| Drug Interactions of Concern to Dentistry | 179 | ||
| Serious Reactions | 179 | ||
| Dental Considerations | 180 | ||
| General: | 180 | ||
| Teach Patient/Family to: | 180 | ||
| budesonide | 180 | ||
| Category and Schedule | 180 | ||
| Drug Class: | 180 | ||
| Mechanism of Action | 180 | ||
| Uses | 180 | ||
| Pharmacokinetics | 180 | ||
| Indications and Dosages | 180 | ||
| ► Rhinitis | 180 | ||
| Intranasal (Rhinocort Aqua) | 180 | ||
| bumetanide | 181 | ||
| Category and Schedule | 181 | ||
| Drug Class: | 181 | ||
| Mechanism of Action | 181 | ||
| Uses | 181 | ||
| Pharmacokinetics | 182 | ||
| Indications and Dosages | 182 | ||
| ► Edema | 182 | ||
| bupivacaine | 183 | ||
| Category and Schedule | 183 | ||
| Drug Class: | 183 | ||
| Mechanism of Action | 183 | ||
| Uses | 183 | ||
| Pharmacokinetics | 183 | ||
| Indications and Dosages | 183 | ||
| ► Analgesic, Epidural (partial to moderate motor blockade) | 183 | ||
| IV | 183 | ||
| Adults, Elderly. | 183 | ||
| Children weighing more than 10 kg. | 183 | ||
| Children weighing less than 10 kg. | 183 | ||
| ► Analgesic, Epidural (moderate to complete motor blockade) | 184 | ||
| buprenorphine hydrochloride | 186 | ||
| Category and Schedule | 186 | ||
| Drug Class: | 186 | ||
| Mechanism of Action | 186 | ||
| Uses | 186 | ||
| Pharmacokinetics: | 186 | ||
| Indications and Dosages | 187 | ||
| ► Analgesia | 187 | ||
| IV, IM | 187 | ||
| Adults, Children older than 12 yr. | 187 | ||
| Children 2–12 yr. | 187 | ||
| Elderly. | 187 | ||
| ► Opioid Dependence | 187 | ||
| Sublingual | 187 | ||
| Adults, Elderly, Children older than 16 yr. | 187 | ||
| Side Effects/Adverse Reactions | 187 | ||
| Frequent | 187 | ||
| Occasional | 187 | ||
| Precautions and Contraindications | 187 | ||
| Caution: | 187 | ||
| Drug Interactions of Concern to Dentistry | 187 | ||
| Serious Reactions | 187 | ||
| Dental Considerations | 187 | ||
| General: | 187 | ||
| Consultations: | 188 | ||
| Teach Patient/Family to: | 188 | ||
| buprenorphine + naloxone | 188 | ||
| Category and Schedule | 188 | ||
| Drug Class: | 188 | ||
| Mechanism of Action | 188 | ||
| Uses | 188 | ||
| Pharmacokinetics | 188 | ||
| Indications and Dosages | 188 | ||
| ► Opioid Dependence | 188 | ||
| Adults. | 188 | ||
| Side Effects/Adverse Reactions | 188 | ||
| Frequent | 188 | ||
| Occasional | 188 | ||
| Precautions and Contraindications | 188 | ||
| Drug Interactions of Concern to Dentistry | 189 | ||
| Serious Reactions | 189 | ||
| Dental Considerations | 189 | ||
| General: | 189 | ||
| Consultations: | 189 | ||
| Teach Patient/Family to: | 189 | ||
| bupropion | 190 | ||
| Category and Schedule | 190 | ||
| Drug Class: | 190 | ||
| Mechanism of Action | 190 | ||
| Uses | 190 | ||
| Pharmacokinetics | 190 | ||
| Indications and Dosages | 190 | ||
| ► Depression | 190 | ||
| PO (Immediate-Release) | 190 | ||
| buspirone hydrochloride | 191 | ||
| Category and Schedule | 191 | ||
| Drug Class: | 191 | ||
| Mechanism of Action | 191 | ||
| Uses | 191 | ||
| Pharmacokinetics | 191 | ||
| Indications and Dosages | 192 | ||
| ► Short-Term Management (up to 4 wk) of Anxiety Disorders | 192 | ||
| PO | 192 | ||
| Adults. | 192 | ||
| Elderly. | 192 | ||
| Children. | 192 | ||
| Side Effects/Adverse Reactions | 192 | ||
| Frequent | 192 | ||
| Occasional | 192 | ||
| Rare | 192 | ||
| Precautions and Contraindications | 192 | ||
| Caution: | 192 | ||
| Drug Interactions of Concern to Dentistry | 192 | ||
| Serious Reactions | 192 | ||
| Dental Considerations | 192 | ||
| General: | 192 | ||
| Consultations: | 192 | ||
| Teach Patient/Family: | 192 | ||
| busulfan | 193 | ||
| Category and Schedule | 193 | ||
| Drug Class: | 193 | ||
| Mechanism of Action | 193 | ||
| Uses | 193 | ||
| Pharmacokinetics | 193 | ||
| Indications and Dosages | 193 | ||
| ► Remission Induction in Chronic Myelogenous Leukemia (CML) | 193 | ||
| butabarbital sodium | 195 | ||
| Category and Schedule | 195 | ||
| Drug Class: | 195 | ||
| Mechanism of Action | 195 | ||
| Uses | 195 | ||
| Pharmacokinetics | 195 | ||
| Indications and Dosages | 195 | ||
| ► Insomnia, Short-Term | 195 | ||
| butenafine | 196 | ||
| Category and Schedule | 196 | ||
| Drug Class: | 196 | ||
| Mechanism of Action | 196 | ||
| Uses | 196 | ||
| Pharmacokinetics | 196 | ||
| Indications and Dosages | 196 | ||
| ► Tinea Pedis, Tinea Corporis, Tinea Cruris, Tinea Versicolor | 196 | ||
| Topical | 196 | ||
| Adults, Elderly, Children 12 yr and older. | 196 | ||
| Side Effects/Adverse Reactions | 196 | ||
| Occasional | 196 | ||
| Rare | 196 | ||
| Precautions and Contraindications | 196 | ||
| Caution: | 196 | ||
| Drug Interactions of Concern to Dentistry | 196 | ||
| Serious Reactions | 196 | ||
| butoconazole | 197 | ||
| Category and Schedule | 197 | ||
| Drug Class: | 197 | ||
| Mechanism of Action | 197 | ||
| Uses | 197 | ||
| Pharmacokinetics | 197 | ||
| Indications and Dosages | 197 | ||
| ► Treatment of Candidiasis | 197 | ||
| Topical | 197 | ||
| Adults, Elderly. | 197 | ||
| Side Effects/Adverse Reactions | 197 | ||
| Occasional | 197 | ||
| Precautions and Contraindications | 197 | ||
| Caution: | 197 | ||
| Serious Reactions | 197 | ||
| Dental Considerations | 197 | ||
| General: | 197 | ||
| Indications and Dosages | 198 | ||
| ► Analgesia | 198 | ||
| IV | 198 | ||
| butorphanol tartrate | 197 | ||
| cabergoline | 200 | ||
| Category and Schedule | 200 | ||
| Drug Class: | 200 | ||
| Mechanism of Action | 200 | ||
| Uses | 200 | ||
| Pharmacokinetics | 200 | ||
| Indications and Dosages | 200 | ||
| ► Hyperprolactinemia (Idiopathic or Primary Pituitary Adenomas) | 200 | ||
| calcifediol | 201 | ||
| Category and Schedule | 201 | ||
| Drug Class: | 201 | ||
| Mechanism of Action | 201 | ||
| Uses | 201 | ||
| Pharmacokinetics | 201 | ||
| Indications and Dosages | 201 | ||
| ► Secondary Hyperparathyroidism | 201 | ||
| PO | 201 | ||
| Adults. | 201 | ||
| Side Effects/Adverse Reactions | 202 | ||
| Frequent | 202 | ||
| Occasional | 202 | ||
| Precautions and Contraindications | 202 | ||
| Drug Interactions of Concern to Dentistry | 202 | ||
| Serious Reactions | 202 | ||
| Dental Considerations | 202 | ||
| General: | 202 | ||
| Consultations: | 202 | ||
| Teach Patient/Family to: | 202 | ||
| calcitonin | 202 | ||
| Category and Schedule | 202 | ||
| Drug Class: | 202 | ||
| Mechanism of Action | 202 | ||
| Uses | 202 | ||
| Pharmacokinetics | 202 | ||
| Indications and Dosages | 203 | ||
| ► Skin Testing Before Treatment in Patients with Suspected Sensitivity to Calcitonin-Salmon | 203 | ||
| Intracutaneous | 203 | ||
| canagliflozin | 204 | ||
| Category and Schedule | 204 | ||
| Drug Class: | 204 | ||
| Mechanism of Action | 204 | ||
| Uses | 204 | ||
| Pharmacokinetics | 204 | ||
| Indications and Dosages | 204 | ||
| ► Type 2 Diabetes Mellitus | 204 | ||
| PO | 204 | ||
| Adults. | 204 | ||
| Side Effects/Adverse Reactions | 204 | ||
| Frequent | 204 | ||
| Occasional | 204 | ||
| Precautions and Contraindications | 204 | ||
| Drug Interactions of Concern to Dentistry | 205 | ||
| Serious Reactions | 205 | ||
| Dental Considerations | 205 | ||
| General: | 205 | ||
| Consultations: | 205 | ||
| Teach Patient/Family to: | 205 | ||
| canakinumab | 205 | ||
| Category and Schedule | 205 | ||
| Drug Class: | 205 | ||
| Mechanism of Action | 205 | ||
| Uses | 205 | ||
| Pharmacokinetics | 205 | ||
| Indications and Dosages | 206 | ||
| ► Cryopyrin-Associated Periodic Syndrome (CAPS) | 206 | ||
| Children ≥4 yr and adolescents. | 206 | ||
| Children ≥4 yr and adolescents >40 kg. | 206 | ||
| ► Systemic Juvenile Idiopathic Arthritis (SJIA) | 206 | ||
| Children ≥2 yr and ≥7.5 kg and adolescents. | 206 | ||
| Side Effects/Adverse Reactions | 206 | ||
| Frequent | 206 | ||
| Occasional | 206 | ||
| Precautions and Contraindications | 206 | ||
| Drug Interactions of Concern to Dentistry | 206 | ||
| Serious Reactions | 206 | ||
| Dental Considerations | 206 | ||
| General: | 206 | ||
| Teach Patient/Family to: | 206 | ||
| candesartan cilexetil | 207 | ||
| Category and Schedule | 207 | ||
| Drug Class: | 207 | ||
| Mechanism of Action | 207 | ||
| Uses | 207 | ||
| Pharmacokinetics | 207 | ||
| Indications and Dosages | 207 | ||
| ► Hypertension Alone or in Combination with Other Antihypertensives | 207 | ||
| PO | 207 | ||
| Adults, Elderly, Patients with mildly impaired liver or renal function. | 207 | ||
| Side Effects/Adverse Reactions | 207 | ||
| Occasional | 207 | ||
| Rare | 207 | ||
| Precautions and Contraindications | 207 | ||
| Caution: | 207 | ||
| Drug Interactions of Concern to Dentistry | 207 | ||
| Serious Reactions | 207 | ||
| Dental Considerations | 207 | ||
| General: | 207 | ||
| Consultations: | 208 | ||
| Teach Patient/Family to: | 208 | ||
| capecitabine | 208 | ||
| Category and Schedule | 208 | ||
| Drug Class: | 208 | ||
| Mechanism of Action | 208 | ||
| Uses | 208 | ||
| Pharmacokinetics | 208 | ||
| Indications and Dosages | 208 | ||
| ► Metastatic Breast Cancer, Colon Cancer | 208 | ||
| PO | 208 | ||
| Adults, Elderly. | 208 | ||
| Side Effects/Adverse Reactions | 208 | ||
| Frequent | 208 | ||
| Occasional | 208 | ||
| Precautions and Contraindications | 208 | ||
| Caution: | 209 | ||
| Drug Interactions of Concern to Dentistry | 209 | ||
| Serious Reactions | 209 | ||
| Dental Considerations | 209 | ||
| General: | 209 | ||
| Consultations: | 209 | ||
| Teach Patient/Family to: | 209 | ||
| caprylidene | 210 | ||
| Category and Schedule | 210 | ||
| Drug Class: | 210 | ||
| Mechanism of Action | 210 | ||
| Uses | 210 | ||
| Pharmacokinetics | 210 | ||
| Indications and Dosages | 210 | ||
| ► Dietary Management of Metabolic Processes Associated with Mild-to-Moderate Alzheimer’s Disease | 210 | ||
| PO | 210 | ||
| Adults. | 210 | ||
| Side Effects/Adverse Reactions | 210 | ||
| Frequent | 210 | ||
| Occasional | 210 | ||
| Precautions and Contraindications | 210 | ||
| Drug Interactions of Concern to Dentistry | 210 | ||
| Serious Reactions | 210 | ||
| Dental Considerations | 210 | ||
| General: | 210 | ||
| Consultations: | 211 | ||
| capsaicin | 211 | ||
| Category and Schedule | 211 | ||
| Drug Class: | 211 | ||
| Mechanism of Action | 211 | ||
| Uses | 211 | ||
| Pharmacokinetics | 211 | ||
| Indications and Dosages | 211 | ||
| ► Treatment of Neuralgia, Osteoarthritis, Rheumatoid Arthritis | 211 | ||
| Topical | 211 | ||
| Adults, Elderly, Children older than 2 yr. | 211 | ||
| Side Effects/Adverse Reactions | 211 | ||
| Frequent | 211 | ||
| Precautions and Contraindications | 211 | ||
| Caution: | 211 | ||
| Drug Interactions of Concern to Dentistry | 211 | ||
| Serious Reactions | 211 | ||
| Dental Considerations | 211 | ||
| General: | 211 | ||
| Teach Patient/Family to: | 211 | ||
| captopril | 212 | ||
| Category and Schedule | 212 | ||
| Drug Class: | 212 | ||
| Mechanism of Action | 212 | ||
| Uses | 212 | ||
| Pharmacokinetics | 212 | ||
| Indications and Dosages | 212 | ||
| ► Hypertension | 212 | ||
| carbachol | 214 | ||
| Category and Schedule | 214 | ||
| Drug Class: | 214 | ||
| Mechanism of Action | 214 | ||
| Uses | 214 | ||
| Pharmacokinetics | 214 | ||
| Indications and Dosages | 214 | ||
| ► Glaucoma | 214 | ||
| carbamazepine | 215 | ||
| Category and Schedule | 215 | ||
| Drug Class: | 215 | ||
| Mechanism of Action | 215 | ||
| Uses | 215 | ||
| Pharmacokinetics | 215 | ||
| Indications and Dosages | 215 | ||
| ► Seizure Control | 215 | ||
| carbamide peroxide | 217 | ||
| Category and Schedule | 217 | ||
| Drug Class: | 217 | ||
| Mechanism of Action | 217 | ||
| Uses | 217 | ||
| Pharmacokinetics | 217 | ||
| Indications and Dosages | 217 | ||
| ► Earwax Removal | 217 | ||
| carbidopa | 218 | ||
| Category and Schedule | 218 | ||
| Drug Class: | 218 | ||
| Mechanism of Action | 218 | ||
| Uses | 218 | ||
| Pharmacokinetics | 218 | ||
| Indications and Dosages | 218 | ||
| ► Parkinson’s Disease | 218 | ||
| PO | 218 | ||
| Adults, Patients receiving carbidopa-levodopa 10/100. | 218 | ||
| Patients receiving carbidopa-levodopa 25/250 or carbidopa-levodopa 25/100. | 218 | ||
| Side Effects/Adverse Reactions | 218 | ||
| Frequent | 218 | ||
| Occasional | 219 | ||
| Precautions and Contraindications | 219 | ||
| Drug Interactions of Concern to Dentistry | 219 | ||
| Serious Reactions | 219 | ||
| Dental Considerations | 219 | ||
| General: | 219 | ||
| Teach Patient/Family to: | 219 | ||
| carbidopa + levodopa | 219 | ||
| Category and Schedule | 219 | ||
| Drug Class: | 219 | ||
| Mechanism of Action | 219 | ||
| Uses | 219 | ||
| Pharmacokinetics | 220 | ||
| Indications and Dosages | 220 | ||
| ► Treatment of Motor Fluctuations in Patients With Advanced Parkinson’s Disease | 220 | ||
| Adults. | 220 | ||
| Side Effects/Adverse Reactions | 220 | ||
| Frequent | 220 | ||
| Occasional | 220 | ||
| Precautions and Contraindications | 220 | ||
| Drug Interactions of Concern to Dentistry | 220 | ||
| Serious Reactions | 220 | ||
| Dental Considerations | 220 | ||
| General: | 220 | ||
| Consultations: | 221 | ||
| Teach Patient/Family to: | 221 | ||
| carbinoxamine maleate | 221 | ||
| Category and Schedule | 221 | ||
| Drug Class: | 221 | ||
| Mechanism of Action | 221 | ||
| Uses | 221 | ||
| Pharmacokinetics | 221 | ||
| Indications and Dosages | 221 | ||
| ► Allergic Rhinitis | 221 | ||
| PO | 221 | ||
| Adults, Children 6 yr and older. | 221 | ||
| Children 18 mo–6 yr. | 221 | ||
| Children 9–18 mo. | 221 | ||
| Side Effects/Adverse Reactions | 221 | ||
| Frequent | 221 | ||
| Occasional | 222 | ||
| Rare | 222 | ||
| Precautions and Contraindications | 222 | ||
| Drug Interactions of Concern to Dentistry | 222 | ||
| Serious Reactions | 222 | ||
| Dental Considerations | 222 | ||
| General: | 222 | ||
| Teach Patient/Family to: | 222 | ||
| carboplatin | 222 | ||
| Category and Schedule | 222 | ||
| Drug Class: | 222 | ||
| Mechanism of Action | 222 | ||
| Uses | 222 | ||
| Pharmacokinetics | 222 | ||
| Indications and Dosages | 222 | ||
| ► Ovarian Carcinoma (Monotherapy) | 222 | ||
| IV | 222 | ||
| Adults. | 222 | ||
| ► Ovarian Carcinoma (Combination Therapy) | 223 | ||
| Adults. | 223 | ||
| Children. | 223 | ||
| ► Dosage in Renal Impairment | 223 | ||
| Side Effects/Adverse Reactions | 223 | ||
| Frequent | 223 | ||
| Occasional | 223 | ||
| Rare | 223 | ||
| Precautions and Contraindications | 223 | ||
| Drug Interactions of Concern to Dentistry | 223 | ||
| Serious Reactions | 223 | ||
| Dental Considerations | 223 | ||
| General: | 223 | ||
| Consultations: | 223 | ||
| Teach Patient/Family to: | 224 | ||
| carglumic acid | 224 | ||
| Category and Schedule | 224 | ||
| Drug Class: | 224 | ||
| Mechanism of Action | 224 | ||
| Uses | 224 | ||
| Pharmacokinetics | 224 | ||
| Indications and Dosages | 224 | ||
| ► Acute Hyperammonemia | 224 | ||
| PO | 224 | ||
| Adults, Children. | 224 | ||
| ► Chronic Hyperammonemia | 225 | ||
| PO | 225 | ||
| Adults, Children. | 225 | ||
| Side Effects/Adverse Reactions | 225 | ||
| Frequent | 225 | ||
| Occasional | 225 | ||
| Precautions and Contraindications | 225 | ||
| Drug Interactions of Concern to Dentistry | 225 | ||
| Serious Reactions | 225 | ||
| Dental Considerations | 225 | ||
| General: | 225 | ||
| Consultations: | 225 | ||
| Teach Patient/Family to: | 225 | ||
| carisoprodol | 225 | ||
| Category and Schedule | 225 | ||
| Drug Class: | 225 | ||
| Mechanism of Action | 225 | ||
| Uses | 225 | ||
| Pharmacokinetics | 225 | ||
| carmustine | 226 | ||
| Category and Schedule | 226 | ||
| Drug Class: | 226 | ||
| Mechanism of Action | 226 | ||
| Uses | 226 | ||
| Pharmacokinetics | 226 | ||
| Indications and Dosages | 226 | ||
| ► Adjunct to Rest, Physical Therapy, Analgesics, and Other Measures for Relief of Discomfort from Acute, Painful Musculoskeletal Conditions | 226 | ||
| PO | 226 | ||
| ► Disseminated Hodgkin’s Disease, Non-Hodgkin’s Lymphoma, Multiple Myeloma, and Primary and Metastatic Brain Tumors in Previously Untreated Patients (Monotherapy) | 226 | ||
| IV (BiCNu) | 226 | ||
| Adults, Elderly. | 226 | ||
| Side Effects/Adverse Reactions | 226 | ||
| Frequent | 226 | ||
| Occasional | 226 | ||
| Precautions and Contraindications | 226 | ||
| Caution: | 226 | ||
| Drug Interactions of Concern to Dentistry | 226 | ||
| Serious Reactions | 226 | ||
| Dental Considerations | 226 | ||
| General: | 226 | ||
| Teach Patient/Family to: | 226 | ||
| Children. | 226 | ||
| ► Implantation (Gliadel) | 226 | ||
| Adults, Elderly, Children. | 226 | ||
| Side Effects/Adverse Reactions | 227 | ||
| Frequent | 227 | ||
| Occasional | 227 | ||
| Rare | 227 | ||
| Precautions and Contraindications | 227 | ||
| Drug Interactions of Concern to Dentistry | 227 | ||
| Serious Reactions | 227 | ||
| Dental Considerations | 227 | ||
| General: | 227 | ||
| Consultations: | 227 | ||
| Teach Patient/Family to: | 227 | ||
| carteolol | 228 | ||
| Category and Schedule | 228 | ||
| Drug Class: | 228 | ||
| Mechanism of Action | 228 | ||
| Uses | 228 | ||
| Pharmacokinetics | 228 | ||
| Indications and Dosages | 228 | ||
| ► Ocular Hypertension | 228 | ||
| PO | 228 | ||
| carvedilol | 230 | ||
| Category and Schedule | 230 | ||
| Drug Class: | 230 | ||
| Mechanism of Action | 230 | ||
| Uses | 230 | ||
| Pharmacokinetics | 230 | ||
| Indications and Dosages | 230 | ||
| ► Hypertension | 230 | ||
| cefaclor | 232 | ||
| Category and Schedule | 232 | ||
| Drug Class: | 232 | ||
| Mechanism of Action | 232 | ||
| Uses | 232 | ||
| Pharmacokinetics | 232 | ||
| Indications and Dosages | 232 | ||
| ► Bronchitis | 232 | ||
| cefadroxil | 233 | ||
| Category and Schedule | 233 | ||
| Drug Class: | 233 | ||
| Mechanism of Action | 233 | ||
| Uses | 234 | ||
| Pharmacokinetics | 234 | ||
| Indications and Dosages | 234 | ||
| ► UTIs | 234 | ||
| cefazolin sodium | 235 | ||
| Category and Schedule | 235 | ||
| Drug Class: | 235 | ||
| Mechanism of Action | 235 | ||
| Uses | 235 | ||
| Pharmacokinetics | 235 | ||
| Indications and Dosages | 235 | ||
| ► Uncomplicated UTIs | 235 | ||
| cefdinir | 237 | ||
| Category and Schedule | 237 | ||
| Drug Class: | 237 | ||
| Mechanism of Action | 237 | ||
| Uses | 237 | ||
| Pharmacokinetics | 237 | ||
| Indications and Dosages | 237 | ||
| ► Community-Acquired Pneumonia | 237 | ||
| cefditoren pivoxil | 238 | ||
| Category and Schedule | 238 | ||
| Drug Class: | 238 | ||
| Mechanism of Action | 238 | ||
| Uses | 239 | ||
| Pharmacokinetics | 239 | ||
| Indications and Dosages | 239 | ||
| ► Pharyngitis, Tonsillitis, Skin Infections | 239 | ||
| cefepime | 240 | ||
| Category and Schedule | 240 | ||
| Drug Class: | 240 | ||
| Mechanism of Action | 240 | ||
| Uses | 240 | ||
| Pharmacokinetics | 240 | ||
| Indications and Dosages | 240 | ||
| ► Pneumonia | 240 | ||
| IV | 240 | ||
| Adults, Elderly. | 240 | ||
| Children 2 mo and older. | 240 | ||
| ► Intraabdominal Infections | 241 | ||
| cefixime | 242 | ||
| Category and Schedule | 242 | ||
| Drug Class: | 242 | ||
| Mechanism of Action | 242 | ||
| Uses | 242 | ||
| Pharmacokinetics | 242 | ||
| Indications and Dosages | 242 | ||
| ► Otitis Media, Acute Bronchitis, Acute Exacerbations of Chronic Bronchitis, Pharyngitis, Tonsillitis, and Uncomplicated UTIs | 242 | ||
| cefonicid sodium | 243 | ||
| Category and Schedule | 243 | ||
| Drug Class: | 243 | ||
| Mechanism of Action | 243 | ||
| Uses | 243 | ||
| Pharmacokinetics | 243 | ||
| Indications and Dosages | 243 | ||
| ► UTIs | 243 | ||
| cefoperazone | 245 | ||
| Category and Schedule | 245 | ||
| Drug Class: | 245 | ||
| Mechanism of Action | 245 | ||
| Uses | 245 | ||
| Pharmacokinetics | 245 | ||
| Indications and Dosages | 245 | ||
| ► Mild to Moderate Infections | 245 | ||
| cefotaxime sodium | 246 | ||
| Category and Schedule | 246 | ||
| Drug Class: | 246 | ||
| Mechanism of Action | 246 | ||
| Uses | 246 | ||
| Pharmacokinetics | 246 | ||
| Indications and Dosages | 246 | ||
| ► Uncomplicated Infections | 246 | ||
| cefotetan disodium | 248 | ||
| Category and Schedule | 248 | ||
| Drug Class: | 248 | ||
| Mechanism of Action | 248 | ||
| Uses | 248 | ||
| Pharmacokinetics | 248 | ||
| Indications and Dosages | 248 | ||
| ► UTIs | 248 | ||
| cefoxitin sodium | 249 | ||
| Category and Schedule | 249 | ||
| Drug Class: | 249 | ||
| Mechanism of Action | 249 | ||
| Uses | 249 | ||
| Pharmacokinetics | 249 | ||
| Indications and Dosages | 250 | ||
| ► Mild to Moderate Infections | 250 | ||
| cefpodoxime proxetil | 251 | ||
| Category and Schedule | 251 | ||
| Drug Class: | 251 | ||
| Mechanism of Action | 251 | ||
| Uses | 251 | ||
| Pharmacokinetics | 251 | ||
| Indications and Dosages | 251 | ||
| ► Chronic Bronchitis, Pneumonia | 251 | ||
| cefprozil | 253 | ||
| Category and Schedule | 253 | ||
| Drug Class: | 253 | ||
| Mechanism of Action | 253 | ||
| Uses | 253 | ||
| Pharmacokinetics | 253 | ||
| Indications and Dosages | 253 | ||
| ► Pharyngitis, Tonsillitis | 253 | ||
| ceftaroline fosamil | 254 | ||
| Category and Schedule | 254 | ||
| Drug Class: | 254 | ||
| Mechanism of Action | 254 | ||
| Uses | 254 | ||
| Pharmacokinetics | 254 | ||
| Indications and Dosages | 254 | ||
| ► Pneumonia, Community-Acquired | 254 | ||
| ceftazidime | 255 | ||
| Category and Schedule | 255 | ||
| Drug Class: | 255 | ||
| Mechanism of Action | 255 | ||
| Uses | 256 | ||
| Pharmacokinetics | 256 | ||
| Indications and Dosages | 256 | ||
| ► UTIs | 256 | ||
| ceftibuten | 257 | ||
| Category and Schedule | 257 | ||
| Drug Class: | 257 | ||
| Mechanism of Action | 257 | ||
| Uses | 257 | ||
| Pharmacokinetics | 257 | ||
| Indications and Dosages | 257 | ||
| ► Chronic Bronchitis | 257 | ||
| ceftizoxime sodium | 259 | ||
| Category and Schedule | 259 | ||
| Drug Class: | 259 | ||
| Mechanism of Action | 259 | ||
| Uses | 259 | ||
| Pharmacokinetics | 259 | ||
| Indications and Dosages | 259 | ||
| ► Uncomplicated UTIs | 259 | ||
| ceftriaxone sodium | 260 | ||
| Category and Schedule | 260 | ||
| Drug Class: | 260 | ||
| Mechanism of Action | 260 | ||
| Uses | 260 | ||
| Pharmacokinetics | 260 | ||
| Indications and Dosages | 260 | ||
| ► Mild to Moderate Infections | 260 | ||
| IV, IM | 260 | ||
| Adults, Elderly. | 260 | ||
| ► Serious Infections | 261 | ||
| cefuroxime axetil/cefuroxime sodium | 262 | ||
| Category and Schedule | 262 | ||
| Drug Class: | 262 | ||
| Mechanism of Action | 262 | ||
| Uses | 262 | ||
| Pharmacokinetics | 262 | ||
| Indications and Dosages | 262 | ||
| ► Ampicillin-Resistant Influenza; Bacterial Meningitis; Early Lyme Disease; GU Tract, Gynecologic, Skin and Bone Infections; Septicemia; Gonorrhea and Other Gonococcal Infections | 262 | ||
| IV, IM | 262 | ||
| celecoxib | 264 | ||
| Category and Schedule | 264 | ||
| Drug Class: | 264 | ||
| Mechanism of Action | 264 | ||
| Uses | 264 | ||
| Pharmacokinetics | 264 | ||
| Indications and Dosages | 264 | ||
| ► Osteoarthritis | 264 | ||
| cephalexin | 265 | ||
| Category and Schedule | 265 | ||
| Drug Class: | 265 | ||
| Mechanism of Action | 265 | ||
| Uses | 266 | ||
| Pharmacokinetics | 266 | ||
| Indications and Dosages | 266 | ||
| ► Bone Infections, Prophylaxis of Rheumatic Fever, Follow-up to Parenteral Therapy | 266 | ||
| cephradine | 267 | ||
| Category and Schedule | 267 | ||
| Drug Class: | 267 | ||
| Mechanism of Action | 267 | ||
| Uses | 267 | ||
| Pharmacokinetics | 267 | ||
| Indications and Dosages | 267 | ||
| ► Mild, Moderate or Severe Infections of the Respiratory and GU Tracts; Bone, Joint and Skin Infections; Prostatitis; Otitis Media | 267 | ||
| PO | 267 | ||
| Adults, Elderly. | 267 | ||
| Children older than 9 mo. | 267 | ||
| ► Dosage in Renal Impairment | 267 | ||
| Side Effects/Adverse Reactions | 268 | ||
| Frequent | 268 | ||
| Occasional | 268 | ||
| Rare | 268 | ||
| Precautions and Contraindications | 268 | ||
| Caution: | 268 | ||
| Drug Interactions of Concern to Dentistry | 268 | ||
| Serious Reactions | 268 | ||
| Dental Considerations | 268 | ||
| General: | 268 | ||
| Consultations: | 268 | ||
| Teach Patient/Family to: | 268 | ||
| certolizumab | 268 | ||
| Category and Schedule | 268 | ||
| Drug Class: | 268 | ||
| Mechanism of Action | 268 | ||
| Uses | 269 | ||
| Pharmacokinetics | 269 | ||
| Indications and Dosages | 269 | ||
| Adult. | 269 | ||
| Pediatric. | 269 | ||
| Side Effects/Adverse Reactions | 269 | ||
| Frequent | 269 | ||
| Occasional | 269 | ||
| Rare | 269 | ||
| Precautions and Contraindications | 269 | ||
| Caution: | 269 | ||
| Drug Interactions of Concern to Dentistry | 269 | ||
| Serious Reactions | 269 | ||
| Dental Considerations | 269 | ||
| General: | 269 | ||
| Consultations: | 269 | ||
| Teach Patient/Family to: | 270 | ||
| cetirizine | 270 | ||
| Category and Schedule | 270 | ||
| Drug Class: | 270 | ||
| Mechanism of Action | 270 | ||
| Uses | 270 | ||
| Pharmacokinetics | 270 | ||
| Indications and Dosages | 270 | ||
| ► Allergic Rhinitis, Urticaria | 270 | ||
| PO | 270 | ||
| Adults, Elderly, Children older than 5 yr. | 270 | ||
| Children 2–5 yr. | 270 | ||
| Children 12–23 mo. | 270 | ||
| Children 6–11 mo. | 270 | ||
| ► Dosage in Renal or Hepatic Impairment | 270 | ||
| Side Effects/Adverse Reactions | 270 | ||
| Occasional | 270 | ||
| Precautions and Contraindications | 270 | ||
| Caution: | 270 | ||
| Drug Interactions of Concern to Dentistry | 270 | ||
| Serious Reactions | 271 | ||
| Dental Considerations | 271 | ||
| General: | 271 | ||
| Teach Patient/Family: | 271 | ||
| cetuximab | 271 | ||
| Category and Schedule | 271 | ||
| Drug Class: | 271 | ||
| Mechanism of Action | 271 | ||
| Uses | 271 | ||
| Pharmacokinetics | 271 | ||
| Indications and Dosages | 271 | ||
| ► Metastatic Colorectal Carcinoma | 271 | ||
| IV | 271 | ||
| Adults, Elderly. | 271 | ||
| Side Effects/Adverse Reactions | 271 | ||
| Frequent | 271 | ||
| Occasional | 271 | ||
| Rare | 271 | ||
| Precautions and Contraindications | 271 | ||
| Drug Interactions of Concern to Dentistry | 271 | ||
| Serious Reactions | 272 | ||
| Dental Considerations | 272 | ||
| General: | 272 | ||
| Consultations: | 272 | ||
| Teach Patient/Family to: | 272 | ||
| cevimeline | 272 | ||
| Category and Schedule | 272 | ||
| Drug Class: | 272 | ||
| Mechanism of Action | 272 | ||
| Uses | 273 | ||
| Pharmacokinetics | 273 | ||
| Indications and Dosages | 273 | ||
| ► Dry Mouth | 273 | ||
| PO | 273 | ||
| Adults. | 273 | ||
| Side Effects/Adverse Reactions | 273 | ||
| Frequent | 273 | ||
| Occasional | 273 | ||
| Rare | 273 | ||
| Precautions and Contraindications | 273 | ||
| Caution: | 273 | ||
| Drug Interactions of Concern to Dentistry | 273 | ||
| Serious Reactions | 273 | ||
| Dental Considerations | 273 | ||
| General: | 273 | ||
| Consultations: | 273 | ||
| Teach Patient/Family to: | 273 | ||
| chloral hydrate | 274 | ||
| Category and Schedule | 274 | ||
| Drug Class: | 274 | ||
| Mechanism of Action | 274 | ||
| Uses | 274 | ||
| Pharmacokinetics | 274 | ||
| Indications and Dosages | 274 | ||
| ► Premedication for Dental or Medical Procedures | 274 | ||
| chlordiazepoxide | 275 | ||
| Category and Schedule | 275 | ||
| Drug Class: | 275 | ||
| Mechanism of Action | 275 | ||
| Uses | 275 | ||
| Pharmacokinetics | 275 | ||
| Indications and Dosages | 275 | ||
| ► Alcohol Withdrawal Symptoms | 275 | ||
| chlorhexidine gluconate | 276 | ||
| Category and Schedule | 276 | ||
| Drug Class: | 276 | ||
| Mechanism of Action | 276 | ||
| Uses | 277 | ||
| Pharmacokinetics | 277 | ||
| Indications and Dosages | 277 | ||
| ► Gingivitis | 277 | ||
| Oral Rinse | 277 | ||
| chloroquine/chloroquine phosphate | 277 | ||
| Category and Schedule | 277 | ||
| Drug Class: | 277 | ||
| Mechanism of Action | 278 | ||
| Uses | 278 | ||
| Pharmacokinetics | 278 | ||
| Indications and Dosages | 278 | ||
| Chloroquine Phosphate | 278 | ||
| ► Treatment of Malaria (Acute Attack): Dose (mg Base) | 278 | ||
| ► Suppression of Malaria | 278 | ||
| chlorothiazide | 279 | ||
| Category and Schedule | 279 | ||
| Drug Class: | 279 | ||
| Mechanism of Action | 279 | ||
| Uses | 279 | ||
| Pharmacokinetics | 279 | ||
| Indications and Dosages | 279 | ||
| ► Edema, Hypertension | 279 | ||
| PO | 279 | ||
| Adults. | 279 | ||
| Children 12 yr and older. | 279 | ||
| Children 2–12 yr. | 279 | ||
| Children 6 mo–2 yr. | 279 | ||
| Children younger than 6 mo. | 280 | ||
| ► Hypertension | 280 | ||
| IV | 280 | ||
| Side Effects/Adverse Reactions | 280 | ||
| Expected | 280 | ||
| Frequent | 280 | ||
| Occasional | 280 | ||
| Precautions and Contraindications | 280 | ||
| Caution: | 280 | ||
| Drug Interactions of Concern to Dentistry | 280 | ||
| Serious Reactions | 280 | ||
| Dental Considerations | 280 | ||
| General: | 280 | ||
| Consultations: | 280 | ||
| Teach Patient/Family to: | 281 | ||
| chlorpheniramine | 281 | ||
| Category and Schedule | 281 | ||
| Drug Class: | 281 | ||
| Mechanism of Action | 281 | ||
| Uses | 281 | ||
| Pharmacokinetics | 281 | ||
| Indications and Dosages | 281 | ||
| ► Allergic Rhinitis, Common Cold | 281 | ||
| PO | 281 | ||
| chlorpromazine | 282 | ||
| Category and Schedule | 282 | ||
| Drug Class: | 282 | ||
| Mechanism of Action | 282 | ||
| Uses | 283 | ||
| Pharmacokinetics | 283 | ||
| Indications and Dosages | 283 | ||
| ► Severe Nausea or Vomiting | 283 | ||
| chlorpropamide | 285 | ||
| Category and Schedule | 285 | ||
| Drug Class: | 285 | ||
| Mechanism of Action | 285 | ||
| Uses | 285 | ||
| Pharmacokinetics | 285 | ||
| Indications and Dosages | 285 | ||
| ► Diabetes Mellitus, Combination Therapy | 285 | ||
| PO | 285 | ||
| Adults. | 285 | ||
| Elderly. | 285 | ||
| ► Renal Function Impairment | 285 | ||
| Side Effects/Adverse Reactions | 285 | ||
| Frequent | 285 | ||
| Occasional | 285 | ||
| Precautions and Contraindications | 285 | ||
| Caution: | 285 | ||
| Drug Interactions of Concern to Dentistry | 285 | ||
| Serious Reactions | 285 | ||
| Dental Considerations | 285 | ||
| General: | 285 | ||
| Consultations: | 286 | ||
| Teach Patient/Family to: | 286 | ||
| chlorthalidone | 286 | ||
| Category and Schedule | 286 | ||
| Drug Class: | 286 | ||
| Mechanism of Action | 286 | ||
| Uses | 286 | ||
| Pharmacokinetics | 286 | ||
| Indications and Dosages | 286 | ||
| ► Hypertension, Edema | 286 | ||
| PO | 286 | ||
| Adults. | 286 | ||
| Elderly. | 286 | ||
| Side Effects/Adverse Reactions | 286 | ||
| Expected | 286 | ||
| Frequent | 286 | ||
| Occasional | 286 | ||
| Rare | 286 | ||
| Precautions and Contraindications | 286 | ||
| Caution: | 287 | ||
| Drug Interactions of Concern to Dentistry | 287 | ||
| Serious Reactions | 287 | ||
| Dental Considerations | 287 | ||
| General: | 287 | ||
| Consultations: | 287 | ||
| Teach Patient/Family to: | 287 | ||
| chlorzoxazone | 287 | ||
| Category and Schedule | 287 | ||
| Drug Class: | 287 | ||
| cholestyramine resin | 288 | ||
| Category and Schedule | 288 | ||
| Drug Class: | 288 | ||
| Mechanism of Action | 288 | ||
| Uses | 288 | ||
| Pharmacokinetics | 288 | ||
| Indications and Dosages | 288 | ||
| ► Musculoskeletal Pain | 288 | ||
| PO | 288 | ||
| Adults, Elderly. | 288 | ||
| Children. | 288 | ||
| Side Effects/Adverse Reactions | 288 | ||
| Frequent | 288 | ||
| Occasional | 288 | ||
| Precautions and Contraindications | 288 | ||
| Caution: | 288 | ||
| Drug Interactions of Concern to Dentistry | 288 | ||
| Serious Reactions | 288 | ||
| Dental Considerations | 288 | ||
| General: | 288 | ||
| Indications and Dosages | 289 | ||
| ► Primary Hypercholesterolemia | 289 | ||
| cholic acid | 289 | ||
| Category and Schedule | 289 | ||
| Drug Class: | 289 | ||
| Mechanism of Action | 289 | ||
| Uses | 289 | ||
| Pharmacokinetics | 289 | ||
| Indications and Dosages | 290 | ||
| ► Bile Acid Synthesis Disorders, Peroxisomal Disorders | 290 | ||
| PO | 290 | ||
| Adults. | 290 | ||
| Side Effects/Adverse Reactions | 290 | ||
| Frequent | 290 | ||
| Occasional | 290 | ||
| Precautions and Contraindications | 290 | ||
| Drug Interactions of Concern to Dentistry | 290 | ||
| Serious Reactions | 290 | ||
| Dental Considerations | 290 | ||
| General: | 290 | ||
| Consultations: | 290 | ||
| Teach Patient/Family to: | 290 | ||
| ciclesonide | 290 | ||
| Category and Schedule | 290 | ||
| Drug Class: | 290 | ||
| Mechanism of Action | 290 | ||
| Pharmacokinetics | 291 | ||
| Indications and Dosages | 291 | ||
| ► Asthma | 291 | ||
| Oral Inhalation (Alvesco) | 291 | ||
| Adults, Children 12 yr and older. | 291 | ||
| ► Allergic Rhinitis | 291 | ||
| Nasal (Omnaris) | 291 | ||
| Adults, Children 6 yr and older. | 291 | ||
| Side Effects/Adverse Reactions | 291 | ||
| Frequent | 291 | ||
| Occasional | 291 | ||
| Rare | 291 | ||
| Precautions and Contraindications | 291 | ||
| Drug Interactions of Concern to Dentistry | 291 | ||
| Serious Reactions | 291 | ||
| Dental Considerations | 291 | ||
| General: | 291 | ||
| Consultations: | 292 | ||
| Teach Patient/Family to: | 292 | ||
| ciclopirox | 292 | ||
| Category and Schedule | 292 | ||
| Drug Class: | 292 | ||
| Mechanism of Action | 292 | ||
| Uses | 292 | ||
| Pharmacokinetics | 292 | ||
| Indications and Dosages | 292 | ||
| ► Tinea Pedis | 292 | ||
| cimetidine | 293 | ||
| Category and Schedule | 293 | ||
| Drug Class: | 293 | ||
| Mechanism of Action | 293 | ||
| Uses | 293 | ||
| Pharmacokinetics | 293 | ||
| Indications and Dosages | 293 | ||
| ► Active Ulcer | 293 | ||
| ciprofloxacin hydrochloride | 295 | ||
| Category and Schedule | 295 | ||
| Drug Class: | 295 | ||
| Mechanism of Action | 295 | ||
| Uses | 295 | ||
| Pharmacokinetics | 295 | ||
| Indications and Dosages | 295 | ||
| ► Mild to Moderate UTIs | 295 | ||
| cisplatin | 297 | ||
| Category and Schedule | 297 | ||
| Drug Class: | 297 | ||
| Mechanism of Action | 297 | ||
| Uses | 297 | ||
| Pharmacokinetics | 297 | ||
| Indications and Dosages | 297 | ||
| ► Advanced Bladder Carcinoma, Metastatic Ovarian Tumors, Metastatic Testicular Tumors | 297 | ||
| IV | 297 | ||
| Adults, Elderly, Children. | 297 | ||
| ► Dosage in Renal Impairment | 297 | ||
| Side Effects/Adverse Reactions | 298 | ||
| Frequent | 298 | ||
| Occasional | 298 | ||
| Rare | 298 | ||
| Precautions and Contraindications | 298 | ||
| Drug Interactions of Concern to Dentistry | 298 | ||
| Serious Reactions | 298 | ||